Pathology Books

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsSECTION 1: HEART, ENDOMYOCARDIAL BIOPSY CONGENITAL/GENETIC 4 Endocardial Fibroelastosis Syndrome Monica P. Revelo, MD, PhD 6 Arrhythmogenic Cardiomyopathy Dylan V. Miller, MD, Jagdish Butany, MBBS, MS, FRCPC, and Monica P. Revelo, MD, PhD 12 Fatty Acid Metabolic Disorders Monica P. Revelo, MD, PhD 14 Mitochondrial Myopathies Monica P. Revelo, MD, PhD 18 Muscular Dystrophies Monica P. Revelo, MD, PhD 22 Glycogen Storage Diseases Monica P. Revelo, MD, PhD 24 Fabry Disease, Heart Monica P. Revelo, MD, PhD 28 LAMP2 Mutation (Danon Disease) Jagdish Butany, MBBS, MS, FRCPC, Amar Ibrahim, MB, ChB, MSc, and Monica P. Revelo, MD, PhD ACQUIRED 30 Amyloid Deposition, Heart Elizabeth H. Hammond, MD and Monica P. Revelo, MD, PhD 38 Hemochromatosis, Heart Philippe Romeo, MD and Monica P. Revelo, MD, PhD 40 Anthracycline Cardiotoxicity Brandon T. Larsen, MD, PhD and Monica P. Revelo, MD, PhD 42 Catecholamine Cardiomyopathy Monica P. Revelo, MD, PhD 44 Cocaine Cardiotoxicity Dylan V. Miller, MD and Brian J. Hall, MD 46 Immune Checkpoint Inhibitor Toxicity Monica P. Revelo, MD, PhD and Dylan V. Miller, MD INFLAMMATORY 50 Lymphocytic Myocarditis Monica P. Revelo, MD, PhD 54 Giant Cell Myocarditis Brandon T. Larsen, MD, PhD and Monica P. Revelo, MD, PhD 56 Eosinophilic (Löffler) Myocarditis Monica P. Revelo, MD, PhD 60 Sarcoidosis, Heart Monica P. Revelo, MD, PhD 62 Acute Rheumatic Carditis Monica P. Revelo, MD, PhD 66 Eosinophilic Granulomatosis With Polyangiitis Monica P. Revelo, MD, PhD 68 Viral Myocarditis Dylan V. Miller, MD, Brian J. Hall, MD, and Nikhil Sangle, MD, FRCPath 70 Toxoplasmosis, Heart Monica P. Revelo, MD, PhD 72 Chagas Disease, Heart Dylan V. Miller, MD and Brian J. Hall, MD 76 Lyme Disease and Rickettsial Myocarditis Dylan V. Miller, MD and Brian J. Hall, MD 80 SARS-CoV-2 (COVID-19)-Related Cardiovascular Disease Dylan V. Miller, MD and Monica P. Revelo, MD, PhD 84 Lupus Erythematosus, Heart Monica P. Revelo, MD, PhD TRANSPLANT REJECTION 90 Acute Cellular Transplant Rejection, Heart Elizabeth H. Hammond, MD and Monica P. Revelo, MD, PhD 96 Antibody-Mediated Transplant Rejection, Heart Elizabeth H. Hammond, MD and Monica P. Revelo, MD, PhD 102 Quilty Lesions Billie Fyfe, MD and Monica P. Revelo, MD, PhD 106 Previous Biopsy Sites, Heart Transplant Billie Fyfe, MD and Monica P. Revelo, MD, PhD 108 Posttransplant Lymphoproliferative Disorder, Heart Dylan V. Miller, MD, Brian J. Hall, MD, and Nikhil Sangle, MD, FRCPath 110 Harvesting Injury/Acute Ischemia, Heart Billie Fyfe, MD and Monica P. Revelo, MD, PhD SECTION 2: HEART, RESECTION HEART EXPLANT 116 Hypertrophic Cardiomyopathy Vidhya Nair, MBBS, MD, FRCPC and Monica P. Revelo, MD, PhD 122 Idiopathic Dilated Cardiomyopathy Dylan V. Miller, MD 126 Ischemic Heart Disease Vidhya Nair, MBBS, MD, FRCPC and Monica P. Revelo, MD, PhD 130 Overview of Coronary Artery Stents Dylan V. Miller, MD 134 Cardiac Allograft Vasculopathy Monica P. Revelo, MD, PhD 140 Radiation Injury, Heart Dylan V. Miller, MD and Philippe Romeo, MD 142 Cardiac Conduction System Disease Dylan V. Miller, MD 150 Ventricular Assist Devices Dylan V. Miller, MD 156 Approach to Cardiomyopathy (Worksheet) Dylan V. Miller, MD 158 Approach to Cardiomyopathy Diagnosis Dylan V. Miller, MD SECTION 3: HEART, TUMORS BENIGN 166 Cardiac Myxoma Dylan V. Miller, MD and Joseph J. Maleszewski, MD 172 Papillary Fibroelastoma Dylan V. Miller, MD and Joseph J. Maleszewski, MD 176 Cardiac Rhabdomyoma Dylan V. Miller, MD and Joseph J. Maleszewski, MD 180 Cardiac Fibroma Dylan V. Miller, MD and Joseph J. Maleszewski, MD 184 Ectopic Tissues, Heart Dylan V. Miller, MD and Joseph J. Maleszewski, MD 186 Lipomatous Hypertrophy of Atrial Septum Dylan V. Miller, MD and Billie Fyfe, MD MALIGNANT 188 Cardiac Lymphoma Dylan V. Miller, MD, Brian J. Hall, MD, and Nikhil Sangle, MD, FRCPath 190 Cardiac Angiosarcoma Joseph J. Maleszewski, MD and Monica P. Revelo, MD, PhD 194 Cardiac Sarcoma, Other Dylan V. Miller, MD and Joseph J. Maleszewski, MD 198 Cardiac Metastases Dylan V. Miller, MD and Jagdish Butany, MBBS, MS, FRCPC SECTION 4: CARDIAC VALVES, NATIVE AORTIC 206 Unicommissural Aortic Valve Dylan V. Miller, MD and Jagdish Butany, MBBS, MS, FRCPC 210 Bicuspid Aortic Valve Jagdish Butany, MBBS, MS, FRCPC, Amar Ibrahim, MB, ChB, MSc, and Monica P. Revelo, MD, PhD 214 Senile Calcific Aortic Stenosis Monica P. Revelo, MD, PhD 218 Discrete Membranous Subaortic Stenosis Dylan V. Miller, MD MITRAL 220 Myxomatous Mitral Valve Disease Dylan V. Miller, MD and Philippe Romeo, MD 224 Rheumatic Heart Disease Dylan V. Miller, MD and Philippe Romeo, MD TRICUSPID 228 Carcinoid Heart Disease Joseph J. Maleszewski, MD and Monica P. Revelo, MD, PhD 232 Ebstein Anomaly Dylan V. Miller, MD and Philippe Romeo, MD PULMONARY 234 Congenital Pulmonary Stenosis Dylan V. Miller, MD and Brian J. Hall, MD ENDOCARDITIS 236 Endocarditis, Native Valve Vidhya Nair, MBBS, MD, FRCPC and Monica P. Revelo, MD, PhD 240 Nonbacterial Thrombotic Endocarditis Vidhya Nair, MBBS, MD, FRCPC and Monica P. Revelo, MD, PhD SECTION 5: CARDIAC VALVES PROSTHETIC 246 Leaflet Degeneration, Prosthetic Valves Jagdish Butany, MBBS, MS, FRCPC and Monica P. Revelo, MD, PhD 250 Thrombosis of Prosthetic Valves Dylan V. Miller, MD, Jagdish Butany, MBBS, MS, FRCPC, and Amar Ibrahim, MB, ChB, MSc 252 Endocarditis, Prosthetic Valve Dylan V. Miller, MD and Jagdish Butany, MBBS, MS, FRCPC 258 Mechanical Heart Valve Prostheses: Modes of Failure Dylan V. Miller, MD, Jagdish Butany, MBBS, MS, FRCPC, and Amar Ibrahim, MB, ChB, MSc 260 Catheter-Deployed Valve Therapies Dylan V. Miller, MD and Monica P. Revelo, MD, PhD SECTION 6: PERICARDIUM INFLAMMATORY 268 Acute Pericarditis Monica P. Revelo, MD, PhD 272 Constrictive Pericarditis Monica P. Revelo, MD, PhD 274 Tuberculous Pericarditis Monica P. Revelo, MD, PhD TUMORS 276 Lymphoma, Pericardium Dylan V. Miller, MD 278 Metastatic Tumor, Pericardium Billie Fyfe, MD and Monica P. Revelo, MD, PhD 282 Mesothelioma, Pericardium Dylan V. Miller, MD and Joseph J. Maleszewski, MD 286 Mesothelial/Monocytic Incidental Cardiac Excrescence Dylan V. Miller, MD SECTION 7: VASCULAR DISEASE ENDARTERECTOMY/ATHERECTOMY/THROMBECTOMY 290 Overview of Peripheral Vascular Specimens Dylan V. Miller, MD and Billie Fyfe, MD 296 Thromboembolus, Vascular Billie Fyfe, MD and Monica P. Revelo, MD, PhD THORACIC AORTA 300 Aortic Degenerative Diseases Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 308 Genetic Diseases of the Aorta Joseph J. Maleszewski, MD and Monica P. Revelo, MD, PhD 312 Noninfectious Aortitis Dylan V. Miller, MD 316 Takayasu Arteritis Dylan V. Miller, MD 320 Aortic Dissection Dylan V. Miller, MD and Billie Fyfe, MD 324 Aortic Coarctation Dylan V. Miller, MD and Monica P. Revelo, MD, PhD ABDOMINAL AORTA 328 Aortic Atherosclerosis and Complications Billie Fyfe, MD and Monica P. Revelo, MD, PhD 334 Chronic Periaortitis and IgG4-Related Disease Dylan V. Miller, MD 336 Mycotic Aneurysm Monica P. Revelo, MD, PhD CORONARY ARTERIES 340 Atherosclerosis, Coronary Monica P. Revelo, MD, PhD 344 Coronary Artery Dissection Monica P. Revelo, MD, PhD 348 Kawasaki Disease Vidhya Nair, MBBS, MD, FRCPC and Monica P. Revelo, MD, PhD 352 Coronary Artery Emboli Monica P. Revelo, MD, PhD TEMPORAL ARTERIES 354 Giant Cell/Temporal Arteritis Dylan V. Miller, MD and Monica P. Revelo, MD, PhD PERIPHERAL VESSELS 358 Buerger Disease (Thromboangiitis Obliterans) Dylan V. Miller, MD and Jagdish Butany, MBBS, MS, FRCPC 362 Fibromuscular Dysplasia Dylan V. Miller, MD and A. Brad Farris, III, MD 368 Segmental Arterial Mediolysis Dylan V. Miller, MD 370 Mönckeberg Medial Calcific Sclerosis Brandon T. Larsen, MD, PhD and Monica P. Revelo, MD, PhD 372 Behçet Disease Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 376 Infectious Vasculitis Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 382 Lymphocytic Venulitis Monica P. Revelo, MD, PhD 384 Varicosities Dylan V. Miller, MD and Billie Fyfe, MD 386 Hypertensive Renovascular Diseases Dylan V. Miller, MD, A. Brad Farris, III, MD, and Brandon T. Larsen, MD, PhD VASCULAR TISSUE GRAFTS 390 Vascular Graft Pseudoaneurysm Jagdish Butany, MBBS, MS, FRCPC, Pooja Gupta, MBBS, DNB, and Monica P. Revelo, MD, PhD SECTION 8: VASCULAR TUMORS BENIGN 396 Hemangioma Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 406 Angiomyolipoma Dylan V. Miller, MD, Satish K. Tickoo, MD, and Victor E. Reuter, MD 410 Glomus Tumor Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 418 Cystic Lymphangioma Monica P. Revelo, MD, PhD 420 Arteriovenous Malformations Dylan V. Miller, MD MALIGNANT 424 Epithelioid Hemangioendothelioma Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 428 Kaposi Sarcoma Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 434 Angiosarcoma Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD SECTION 9: AUTOPSY CARDIAC 442 Coronary Artery Bypass Grafting Dylan V. Miller, MD 446 Valve Replacement (Including Transcatheter) Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 452 Infective Endocarditis Dylan V. Miller, MD 458 Ventricular Assist Device Insertion Dylan V. Miller, MD and Brandon T. Larsen, MD, PhD 462 Heart Transplant Dylan V. Miller, MD VASCULAR 468 Thoracic Aortic Aneurysm Repair Dylan V. Miller, MD, Billie Fyfe, MD, and George P. Batsides, MD 474 Abdominal Aortic Aneurysm Dylan V. Miller, MD and Billie Fyfe, MD 478 Cerebral Aneurysm and Vascular Malformation Dylan V. Miller, MD and Roy H. Rhodes, MD, PhD

Read more less

Book SynopsisTable of ContentsIntroduction Methods (Surgery, Histological methods, Stereotaxic reference system and correcting for shrinkage, Delineation of structures) References Index of structures Index of abbreviations Figures: Color plates in stereotaxic coordinates Appendixes: TH staining, ChAT staining

Read more less

Book SynopsisGreenfield's is the worldâs leading neuropathology reference. It provides a comprehensive account of the pathological findings in neurological disease, their biological basis, and their clinical manifestations. The two volume work provides a remarkable text which is clear, comprehensive and precise with exceptional illustrations. The tenth edition features fully updated sections covering CNS tumours, neurodegeneration, skeletal muscle, epilepsy, paediatric and forensic neuropathology.Expert coverage from an international team of Editors and contributors ensures authoritative and up to date content. The two volume set includes a downloadable and easily used e-version. This is a tried and tested reference for scientists, clinicians, researchers, and students who wish to learn more about neurological disease.

Read more less

Book SynopsisTable of ContentsSECTION 1: INTRODUCTION AND OVERVIEW 4 Introduction to Renal Pathology Robert B. Colvin, MD 24 Normal Kidney Structure Neeraja Kambham, MD and Anthony Chang, MD 36 Normal Kidney Development Sanjay Jain, MD, PhD 46 Kidney Biopsy Reports Surya V. Seshan, MD, Anthony Chang, MD, and Lynn D. Cornell, MD 48 Needle Biopsy: Evaluation for Adequacy Lynn D. Cornell, MD 52 Harmonized Nephropathology Terminology and Reporting Mark Haas, MD, PhD 54 Consensus Definitions of Light and Electron Microscopy Lesions Mark Haas, MD, PhD 58 Common Artifacts and Pitfalls Lynn D. Cornell, MD SECTION 2: GLOMERULAR DISEASES PODOCYTOPATHIES 66 Minimal Change Disease (Diffuse Podocytopathy) A. Brad Farris, III, MD, MBA and Astrid Weins, MD, PhD 74 Classification of Focal Segmental Glomerulosclerosis A. Brad Farris, III, MD, MBA and Astrid Weins, MD, PhD 78 Etiologic Classification of Focal Segmental Glomerulosclerosis Robert B. Colvin, MD 80 Focal Segmental Glomerulosclerosis, Primary A. Brad Farris, III, MD, MBA and Astrid Weins, MD, PhD 88 Focal Segmental Glomerulosclerosis, Adaptive (Secondary) A. Brad Farris, III, MD, MBA and Astrid Weins, MD, PhD 94 Collapsing Glomerulopathy A. Brad Farris, III, MD, MBA and Astrid Weins, MD, PhD MEMBRANOUS NEPHROPATHY AND VARIANTS 104 Introduction to Membranous Nephropathy Robert B. Colvin, MD and Anthony Chang, MD 112 Etiologies of Membranous Nephropathy Anthony Chang, MD and Robert B. Colvin, MD 114 Membranous Nephropathy Due to PLA2R1 Autoantibodies Anthony Chang, MD and Sanjeev Sethi, MD 120 Membranous Nephropathy Due to Non-PLA2R1 Autoantibodies Anthony Chang, MD and Sanjeev Sethi, MD 126 Membranous Nephropathy Associated With Systemic Disease Anthony Chang, MD 130 Membranous Nephropathy With Anti-TBM Antibodies Robert B. Colvin, MD 132 Podocyte Infolding Glomerulopathy Shane Meehan, MB, BCh IGA-RELATED GLOMERULONEPHRITIDES 134 Overview of IgA-Related Glomerular Diseases Shane Meehan, MB, BCh 138 IgA Nephropathy Lynn D. Cornell, MD, Robert B. Colvin, MD, and Ian Roberts, MBChB, FRCPath 152 IgA Vasculitis (Henoch-Schönlein Purpura) Anthony Chang, MD and Ian Roberts, MBChB, FRCPath 158 IgA Acute Glomerulonephritis Associated With Staphylococcus aureus Robert B. Colvin, MD and Ian Roberts, MBChB, FRCPath 162 Hepatic Disease With IgA Deposition Robert B. Colvin, MD SLE AND RELATED AUTOANTIBODYMEDIATED DISEASES 164 Systemic Lupus Erythematosus Shane Meehan, MB, BCh, Robert B. Colvin, MD, and Ingeborg M. Bajema, MD, PhD 182 Mixed Connective Tissue Disease A. Brad Farris, III, MD, MBA 184 Idiopathic Nonlupus Full-House Nephropathy Ingeborg M. Bajema, MD, PhD and Emilie Rijnink, MD, PhD 186 Mixed Cryoglobulinemic Glomerulonephritis A. Brad Farris, III, MD, MBA and Charles E. Alpers, MD ANTI-GBM DISEASES 192 Anti-GBM Glomerulonephritis Anthony Chang, MD 200 Atypical Anti-GBM Disease Lynn D. Cornell, MD COMPLEMENT-RELATED GLOMERULONEPHRITIDES 204 Classification of MPGN and Complement-Related Diseases Jean Hou, MD, Robert B. Colvin, MD, and Mark Haas, MD, PhD 210 Dense Deposit Disease Jean Hou, MD, Mark Haas, MD, PhD, and A. Brad Farris, III, MD, MBA 218 C3 Glomerulonephritis Jean Hou, MD, Lynn D. Cornell, MD, and Mark Haas, MD, PhD 226 C1q Nephropathy Neeraja Kambham, MD 232 C4 Glomerulopathy Sanjeev Sethi, MD and Lynn D. Cornell, MD 234 Immune Complex Membranoproliferative Glomerulonephritis Jean Hou, MD, A. Brad Farris, III, MD, MBA, and Mark Haas, MD, PhD MONOCLONAL IMMUNOGLOBULIN GLOMERULAR DISEASES 242 Introduction to Diseases With Monoclonal Immunoglobulin Deposits Robert B. Colvin, MD 246 Monoclonal Immunoglobulin Deposition Disease Lynn D. Cornell, MD 254 Proliferative Glomerulonephritis With Monoclonal IgG Deposits Lynn D. Cornell, MD 258 Membranous Nephropathy With Masked IgG-Kappa Deposits Christopher P. Larsen, MD and Tiffany Caza, MD, PhD 262 Type I Cryoglobulinemic Glomerulonephritis Evan Farkash, MD, PhD and Robert B. Colvin, MD 266 Waldenström Macroglobulinemia Anthony Chang, MD 268 Crystalglobulin Glomerulonephritis Mariam Priya Alexander, MD 270 Light Chain Crystalline Podocytopathy Lynn D. Cornell, MD AMYLOIDOSIS 272 Amyloidosis Classification A. Brad Farris, III, MD, MBA and Sanjeev Sethi, MD 278 AL/AH Amyloidosis A. Brad Farris, III, MD, MBA and Sanjeev Sethi, MD 284 AA Amyloidosis A. Brad Farris, III, MD, MBA and Sanjeev Sethi, MD 288 AFib Amyloidosis A. Brad Farris, III, MD, MBA and Sanjeev Sethi, MD 290 AGel Amyloidosis Sanjeev Sethi, MD 292 ALECT2 Amyloidosis Christopher P. Larsen, MD, Sanjeev Sethi, MD, and Tiffany Caza, MD, PhD 294 AApoAI Amyloidosis A. Brad Farris, III, MD, MBA and Sanjeev Sethi, MD 295 AApoAII Amyloidosis Robert B. Colvin, MD and Sanjeev Sethi, MD 296 AApoAIV Amyloidosis Sanjeev Sethi, MD 297 AApoCII Amyloidosis Sanjeev Sethi, MD 298 ATTR Amyloidosis A. Brad Farris, III, MD, MBA and Sanjeev Sethi, MD IDIOPATHIC FIBRILLARY GLOMERULOPATHIES 300 Diseases With Organized Deposits Robert B. Colvin, MD 304 Fibrillary Glomerulopathy Anthony Chang, MD and Mariam Priya Alexander, MD 310 Immunotactoid Glomerulopathy Anthony Chang, MD and Charles E. Alpers, MD 314 Fibronectin Glomerulopathy Neeraja Kambham, MD DIABETIC AND RELATED RENAL DISEASES 318 Diabetic Nephropathy Neeraja Kambham, MD and Ian Roberts, MBChB, FRCPath 328 Metabolic Syndrome/Obesity-Related Glomerular Disease Shane Meehan, MB, BCh 332 Idiopathic Nodular Glomerulopathy A. Brad Farris, III, MD, MBA and Ian Roberts, MBChB, FRCPath INFECTION-RELATED GLOMERULAR DISEASES 336 Overview of Infection-Related Glomerular Disease Shane Meehan, MB, BCh 340 Acute Poststreptococcal Glomerulonephritis A. Brad Farris, III, MD, MBA 348 Postinfectious Glomerulonephritis, Nonstreptococcal A. Brad Farris, III, MD, MBA 354 Glomerulonephritis of Chronic Infection, Including Shunt Nephritis A. Brad Farris, III, MD, MBA 356 Endocarditis A. Brad Farris, III, MD, MBA and Christie L. Boils, MD 360 Syphilis Shane Meehan, MB, BCh 362 Lyme Disease Neeraja Kambham, MD 364 COVID-19 Nephropathies Lynn D. Cornell, MD, Mariam Priya Alexander, MD, and Robert B. Colvin, MD 372 Hepatitis B Virus Anthony Chang, MD 376 Hepatitis C Virus Anthony Chang, MD and Charles E. Alpers, MD 382 HIV-Associated Nephropathy A. Brad Farris, III, MD, MBA 388 Miscellaneous HIV-Associated Renal Diseases A. Brad Farris, III, MD, MBA 394 Schistosomiasis Neeraja Kambham, MD 396 Filariasis Christie L. Boils, MD 397 Leishmaniasis Kerstin Amann, MD and Robert B. Colvin, MD DRUG-INDUCED GLOMERULAR DISEASES 398 Drug-Induced Minimal Change Disease Anthony Chang, MD and Astrid Weins, MD, PhD 400 Bisphosphonate-Induced Collapsing Glomerulopathy A. Brad Farris, III, MD, MBA and Astrid Weins, MD, PhD 401 Chloroquine Toxicity Shane Meehan, MB, BCh 402 Antihepatitis C Virus Drugs Ivy A. Rosales, MD 406 Anti-EGFR Drugs Kammi J. Henriksen, MD GENETIC GLOMERULAR DISEASES 408 Classification of Glomerular Genetic Diseases Sanjay Jain, MD, PhD 410 Genetic Causes of Nephrotic Syndrome Joseph P. Gaut, MD, PhD GENETIC DISEASES OF GBM COLLAGEN 414 Alport Syndrome Joseph P. Gaut, MD, PhD, Helen Liapis, MD, and Robert B. Colvin, MD 426 Thin Basement Membrane Disease Joseph P. Gaut, MD, PhD and Helen Liapis, MD GENETIC PODOCYTE DISEASES 428 Congenital Nephrotic Syndrome of Finnish Type Joseph P. Gaut, MD, PhD and Helen Liapis, MD 432 Pierson Syndrome Nidia Messias, MD, Joseph P. Gaut, MD, PhD, and Helen Liapis, MD 434 Galloway-Mowat Syndrome Carrie L. Phillips, MD and Stephen M. Bonsib, MD 436 Denys-Drash Syndrome Kammi J. Henriksen, MD and Stephen M. Bonsib, MD 440 Frasier Syndrome Carrie L. Phillips, MD and Stephen M. Bonsib, MD 442 Podocin Deficiency Joseph P. Gaut, MD, PhD and Helen Liapis, MD 444 a-Actinin-4 Deficiency Joseph P. Gaut, MD, PhD and Helen Liapis, MD 446 Autosomal Dominant FSGS Due to INF2 Mutations Robert B. Colvin, MD 448 APOL1-Related Glomerular Disease Christopher P. Larsen, MD and Tiffany Caza, MD, PhD 452 Schimke Immunoosseous Dysplasia Shane Meehan, MB, BCh GENETIC STORAGE AND LIPID DISEASES 454 Fabry Disease Robert B. Colvin, MD and Laura Barisoni, MD 462 Alagille Syndrome Anthony Chang, MD 464 Lecithin Cholesterol Acyltransferase Deficiency Carrie L. Phillips, MD and Stephen M. Bonsib, MD 468 APOE Lipoprotein Glomerulopathy Joseph P. Gaut, MD, PhD and Helen Liapis, MD 470 Type III Hyperlipoproteinemia Nidia Messias, MD, Joseph P. Gaut, MD, PhD, and Helen Liapis, MD 472 I-Cell Disease (Mucolipidosis II) Carrie L. Phillips, MD and Stephen M. Bonsib, MD 474 Gaucher Glomerulopathy A. Brad Farris, III, MD, MBA OTHER GENETIC GLOMERULAR DISEASES 476 Type III Collagen Glomerulopathy Nidia Messias, MD, L. Nicholas Cossey, MD, and Helen Liapis, MD 480 Nail-Patella Syndrome Nidia Messias, MD and Helen Liapis, MD 482 Glomerulopathy of Hereditary Multiple Exostoses Robert B. Colvin, MD and Ian Roberts, MBChB, FRCPath MISCELLANEOUS GLOMERULAR DISEASES 484 Cryofibrinogenic Glomerulopathy Lynn D. Cornell, MD and Mariam Priya Alexander, MD 488 IgM Nephropathy Neeraja Kambham, MD 490 Kidney Disease Associated With COVID-19 Immunization Astrid Weins, MD, PhD and Robert B. Colvin, MD 494 Renal Disease in Rheumatoid Arthritis Neeraja Kambham, MD 500 Hemophagocytic Glomerulopathy Lynn D. Cornell, MD 504 Coenzyme-Q Nephropathies Laura Barisoni, MD 506 Hepatic Glomerulosclerosis Robert B. Colvin, MD 507 Intravascular Large B-Cell Lymphoma Anthony Chang, MD SECTION 3: VASCULAR DISEASES 510 Overview and Classification of Systemic Vasculitides Surya V. Seshan, MD and Ingeborg M. Bajema, MD, PhD ANCA DISEASES 520 ANCA-Related Glomerulonephritis Surya V. Seshan, MD and Ingeborg M. Bajema, MD, PhD 526 Microscopic Polyangiitis Surya V. Seshan, MD and Ingeborg M. Bajema, MD, PhD 534 Granulomatosis With Polyangiitis Surya V. Seshan, MD and Ingeborg M. Bajema, MD, PhD 544 Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) Surya V. Seshan, MD and Ingeborg M. Bajema, MD, PhD 550 Drug-Induced ANCA Vasculitis Surya V. Seshan, MD and Ingeborg M. Bajema, MD, PhD NON-ANCA DISEASES 554 Polyarteritis Nodosa Surya V. Seshan, MD 560 Kawasaki Disease Surya V. Seshan, MD and Yael K. Heher, MD, MPH, FRCP(C) 562 Giant Cell Arteritis Surya V. Seshan, MD 566 Takayasu Arteritis Surya V. Seshan, MD 570 Hypocomplementemic Urticarial Vasculitis (Anti-C1q Vasculitis) Robert B. Colvin, MD THROMBOTIC MICROANGIOPATHIES 572 Introduction to Thrombotic Microangiopathies Neeraja Kambham, MD and Ivy A. Rosales, MD 578 Infection-Related Hemolytic Uremic Syndrome Neeraja Kambham, MD and Ivy A. Rosales, MD 584 Genetic Thrombotic Microangiopathy Neeraja Kambham, MD and Ivy A. Rosales, MD 588 Autoimmune Thrombotic Microangiopathy Neeraja Kambham, MD and Ivy A. Rosales, MD 592 Drug-Induced Thrombotic Microangiopathy Neeraja Kambham, MD and Ivy A. Rosales, MD 596 Postpartum Hemolytic Uremic Syndrome Neeraja Kambham, MD and Ivy A. Rosales, MD 600 Scleroderma Renal Disease Neeraja Kambham, MD and Ivy A. Rosales, MD 606 Multicentric Castleman Disease Lynn D. Cornell, MD OTHER DISEASES AFFECTING ENDOTHELIUM 608 Preeclampsia, Eclampsia, and HELLP Syndrome Anthony Chang, MD 610 Radiation Nephropathy Anthony Chang, MD 612 Sickle Cell Nephropathy Anthony Chang, MD 616 Retinal Vasculopathy and Cerebral Leukodystrophy Robert B. Colvin, MD HYPERTENSIVE RENAL DISEASES 618 Hypertensive Renovascular Diseases A. Brad Farris, III, MD, MBA 626 Renal Artery Stenosis A. Brad Farris, III, MD, MBA 630 Fibromuscular Dysplasia A. Brad Farris, III, MD, MBA 636 Neurofibromatosis Kammi J. Henriksen, MD and Stephen M. Bonsib, MD THROMBOTIC AND EMBOLIC DISEASES 640 Renal Vein Thrombosis Anthony Chang, MD and Yael K. Heher, MD, MPH, FRCP(C) 642 Renal Artery Thrombosis Anthony Chang, MD 644 Atheromatous Emboli Anthony Chang, MD 646 Hydrophilic Polymer Emboli Kammi J. Henriksen, MD SECTION 4: TUBULOINTERSTITIAL DISEASES 650 Overview and Classification of Tubulointerstitial Diseases Robert B. Colvin, MD 652 Differential Diagnosis of Acute Interstitial Nephritis Lynn D. Cornell, MD 658 Granulomatous Interstitial Nephritis Ivy A. Rosales, MD 662 Guide to Crystal Nephropathies L. Nicholas Cossey, MD ISCHEMIC INJURIES 668 Acute Tubular Injury Shane Meehan, MB, BCh 674 Renal Cortical Necrosis Shane Meehan, MB, BCh 676 Sepsis/Shock Joseph P. Gaut, MD, PhD IMMUNOLOGIC TUBULAR DISEASES 678 IgG4-Related Disease Lynn D. Cornell, MD 688 Sjögren Syndrome Josephine M. Ambruzs, MD, MPH 692 Tubulointerstitial Nephritis and Uveitis A. Brad Farris, III, MD, MBA 696 Sarcoidosis Josephine M. Ambruzs, MD, MPH 700 Antibrush Border Autoantibody Tubulointerstitial Nephritis Ivy A. Rosales, MD and Robert B. Colvin, MD 702 Anti-TBM Disease Robert B. Colvin, MD 704 Tubulointerstitial Nephritis With IgM(+) Plasma Cells Lynn D. Cornell, MD MONOCLONAL IMMUNOGLOBULIN TUBULOINTERSTITIAL DISEASES 706 Light Chain Cast Nephropathy Anthony Chang, MD and Kammi J. Henriksen, MD 712 Light Chain Proximal Tubulopathy With Crystals Lynn D. Cornell, MD 716 Light Chain Proximal Tubulopathy Without Crystals Christopher P. Larsen, MD and Tiffany Caza, MD, PhD 720 Crystal-Storing Histiocytosis Mariam Priya Alexander, MD DRUG-INDUCED TUBULOINTERSTITIAL DISEASES 724 Drug-Induced Acute Interstitial Nephritis Lynn D. Cornell, MD and Robert B. Colvin, MD 730 Drugs That Cause Tubulointerstitial Nephritis Robert B. Colvin, MD and Lynn D. Cornell, MD 732 Checkpoint Inhibitor-Induced Kidney Diseases Ivy A. Rosales, MD 736 Papillary Necrosis Neeraja Kambham, MD 740 Cisplatin Nephrotoxicity Shane Meehan, MB, BCh 742 Osmotic Tubulopathy Shane Meehan, MB, BCh and Evan Farkash, MD, PhD 746 Antiviral Drug Nephrotoxicity Shane Meehan, MB, BCh 752 Acute Phosphate Nephropathy Lynn D. Cornell, MD 754 Lithium-Induced Renal Disease Anthony Chang, MD and Yael K. Heher, MD, MPH, FRCP(C) 756 Calcineurin Inhibitor Toxicity Shane Meehan, MB, BCh 762 mTOR Inhibitor Toxicity Lynn D. Cornell, MD 764 Vancomycin-Induced Cast Nephropathy Kammi J. Henriksen, MD 766 Anticoagulant-Related Nephropathy Christopher P. Larsen, MD and Tiffany Caza, MD, PhD 768 Illicit Drugs and Opioids Kammi J. Henriksen, MD TOXIC TUBULOPATHIES 770 Myoglobinuria/Rhabdomyolysis/Hemoglobinuria Neeraja Kambham, MD 772 Bile Cast Nephropathy Anthony Chang, MD 774 Lead and Other Heavy Metal Toxins Shane Meehan, MB, BCh 778 Ethylene Glycol Toxicity Shane Meehan, MB, BCh 780 Aristolochic Acid Nephropathy Shane Meehan, MB, BCh 782 Balkan Endemic Nephropathy Shane Meehan, MB, BCh 784 Argyria Robert B. Colvin, MD AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASES 786 MUC1-Related Autosomal Dominant Tubulointerstitial Kidney Disease Joseph P. Gaut, MD, PhD and Helen Liapis, MD 788 UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease Shane Meehan, MB, BCh 790 REN-Related Autosomal Dominant Tubulointerstitial Kidney Disease Lynn D. Cornell, MD 792 HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease Robert B. Colvin, MD and Marie Claire Gubler, MD GENETIC CRYSTAL DEPOSITION DISEASES 794 Uric Acid Nephropathy/Gout Shane Meehan, MB, BCh 798 Primary Hyperoxaluria Shane Meehan, MB, BCh 800 2,8-Dihydroxyadeninuria Lynn D. Cornell, MD 802 Cystinosis Nidia Messias, MD, Joseph P. Gaut, MD, PhD, and Helen Liapis, MD GENETIC TRANSPORT DISEASES 804 Bartter Syndrome Shane Meehan, MB, BCh 806 Dent Disease Lynn D. Cornell, MD 808 Oculocerebrorenal Syndrome of Lowe Josephine M. Ambruzs, MD, MPH OTHER GENETIC TUBULAR DISEASES 810 Mitochondriopathies Surya V. Seshan, MD 814 Systemic Karyomegaly Robert B. Colvin, MD 816 Methylmalonic Acidemia Lynn D. Cornell, MD and Linda Hasadsri, MD, PhD MISCELLANEOUS TUBULOINTERSTITIAL DISEASES 820 Nephrocalcinosis Lynn D. Cornell, MD 822 Lysozyme Nephropathy Tiffany Caza, MD, PhD and Christopher P. Larsen, MD 824 Secondary Oxalosis Lynn D. Cornell, MD 826 Chronic Interstitial Nephritis in Agricultural Communities Lynn D. Cornell, MD 828 Extramedullary Hematopoiesis Lynn D. Cornell, MD SECTION 5: KIDNEY INFECTIONS BACTERIAL INFECTIONS 834 Acute Pyelonephritis Neeraja Kambham, MD 842 Chronic Pyelonephritis Neeraja Kambham, MD 846 Xanthogranulomatous Pyelonephritis Neeraja Kambham, MD and Ivy A. Rosales, MD 850 Malakoplakia Neeraja Kambham, MD 854 Tuberculosis Neeraja Kambham, MD 856 BCG Granulomatous Interstitial Nephritis Neeraja Kambham, MD 858 Leprosy Neeraja Kambham, MD 859 Megalocytic Interstitial Nephritis Neeraja Kambham, MD 860 Nocardiosis Neeraja Kambham, MD 862 Leptospirosis Shane Meehan, MB, BCh 864 Whipple Disease Carrie L. Phillips, MD FUNGAL, RICKETTSIAL, AND PARASITIC INFECTIONS 866 Mucormycosis Anthony Chang, MD 868 Candidiasis Anthony Chang, MD 869 Histoplasmosis Anthony Chang, MD 870 Coccidioidomycosis Anthony Chang, MD 871 Blastomycosis Anthony Chang, MD 872 Paracoccidioidomycosis Anthony Chang, MD 873 Aspergillosis Anthony Chang, MD 874 Cryptococcosis Anthony Chang, MD 875 Microsporidiosis Robert B. Colvin, MD 876 Rickettsial Infections Shane Meehan, MB, BCh 878 Toxoplasmosis Neeraja Kambham, MD 880 Hydatidosis Carrie L. Phillips, MD and Stephen M. Bonsib, MD VIRAL INFECTIONS 882 Polyomavirus Nephritis Anthony Chang, MD and Evan Farkash, MD, PhD 890 Cytomegalovirus Infection Anthony Chang, MD and R. Neal Smith, MD, PhD 892 Adenovirus Infection Anthony Chang, MD and R. Neal Smith, MD, PhD 894 Epstein-Barr Virus Nephritis Anthony Chang, MD and R. Neal Smith, MD, PhD 896 Herpes Simplex Acute Nephritis Anthony Chang, MD and R. Neal Smith, MD, PhD 898 Hantavirus Nephropathy A. Brad Farris, III, MD, MBA SECTION 6: DEVELOPMENTAL DISEASES 902 Overview of Congenital Anomalies of Kidney and Urinary Tract Sanjay Jain, MD, PhD 906 Dysplasia/Hypoplasia/Agenesis Sanjay Jain, MD, PhD 912 Oligomeganephronia Robert B. Colvin, MD and Yael K. Heher, MD, MPH, FRCP(C) 914 Ectopia, Malrotation, Duplication, Fusion, Supernumerary Kidney Sanjay Jain, MD, PhD 918 Ask-Upmark Kidney Lynn D. Cornell, MD 920 Renal Tubular Dysgenesis Carrie L. Phillips, MD and Stephen M. Bonsib, MD SECTION 7: CYSTIC DISEASES 926 Overview of Cystic Diseases Nidia Messias, MD, Joseph P. Gaut, MD, PhD, and Helen Liapis, MD CILIOPATHIES 932 Autosomal Dominant Polycystic Kidney Disease Anthony Chang, MD, Robert B. Colvin, MD, and Yael K. Heher, MD, MPH, FRCP(C) 938 Autosomal Recessive Polycystic Kidney Disease Carrie L. Phillips, MD and Stephen M. Bonsib, MD 944 Nephronophthisis and Related Ciliopathies Kerstin Amann, MD, Helen Liapis, MD, and Robert B. Colvin, MD OTHER GENETIC CYSTIC DISEASES 950 von Hippel-Lindau Disease Carrie L. Phillips, MD and Stephen M. Bonsib, MD 956 Tuberous Sclerosis Complex Christie L. Boils, MD 962 Zellweger Syndrome Carrie L. Phillips, MD and Stephen M. Bonsib, MD MISCELLANEOUS CYSTIC DISEASES 964 Medullary Sponge Kidney Lynn D. Cornell, MD 966 Mixed Epithelial and Stromal Tumor Family Carrie L. Phillips, MD and Stephen M. Bonsib, MD 972 Pediatric Cystic Nephroma Angelica R. Putnam, MD and Carrie L. Phillips, MD 976 Acquired Cystic Disease Carrie L. Phillips, MD and Stephen M. Bonsib, MD 980 Simple and Miscellaneous Cysts Anthony Chang, MD 982 Renal Lymphangioma/Lymphangiectasia Carrie L. Phillips, MD and Stephen M. Bonsib, MD SECTION 8: COLLECTING SYSTEM DISEASES 988 Introduction to Impediments to Urine Flow Sanjay Jain, MD, PhD 992 Reflux Nephropathy Sanjay Jain, MD, PhD 996 Obstructive Uropathy Sanjay Jain, MD, PhD 1000 Nephrolithiasis Shane Meehan, MB, BCh 1006 Loin Pain Hematuria Syndrome Carrie L. Phillips, MD and Stephen M. Bonsib, MD SECTION 9: RENAL ALLOGRAFT DISEASES 1010 Pathologic Classification of Renal Allograft Diseases Robert B. Colvin, MD INTRODUCTION 1012 Evaluation of Allograft Kidneys Lynn D. Cornell, MD and Evan Farkash, MD, PhD 1018 Evaluation of Donor Kidneys Lynn D. Cornell, MD and Evan Farkash, MD, PhD REJECTION 1024 Acute T-Cell-Mediated Rejection Lynn D. Cornell, MD and Michael Mengel, MD 1034 Chronic T-Cell-Mediated Rejection Lynn D. Cornell, MD and Michael Mengel, MD 1038 Hyperacute Rejection Lynn D. Cornell, MD and Michael Mengel, MD 1042 Acute Antibody-Mediated Rejection Lynn D. Cornell, MD and Michael Mengel, MD 1050 Chronic Antibody-Mediated Rejection Lynn D. Cornell, MD and Michael Mengel, MD 1062 Transcript Analysis of Renal Transplant Biopsies Michael Mengel, MD and R. Neal Smith, MD, PhD RECURRENT AND DE NOVO DISEASES 1066 Diseases That Recur in Allografts Anthony Chang, MD, Lynn D. Cornell, MD, and R. Neal Smith, MD, PhD 1072 De Novo Focal Segmental Glomerulosclerosis Anthony Chang, MD and Astrid Weins, MD, PhD 1074 De Novo Membranous Nephropathy Anthony Chang, MD 1078 Anti-GBM Disease in Alport Syndrome Anthony Chang, MD and R. Neal Smith, MD, PhD 1080 Chimerism Transition Syndrome A. Brad Farris, III, MD, MBA 1082 Late Posttransplant Histology Lynn D. Cornell, MD OTHER ALLOGRAFT DISEASES 1084 Acute Allograft Ischemia A. Brad Farris, III, MD, MBA 1088 Size Mismatch Allograft Injury Anthony Chang, MD and Yael K. Heher, MD, MPH, FRCP(C) 1090 Lymphocele A. Brad Farris, III, MD, MBA 1091 Transplant Renal Artery Stenosis A. Brad Farris, III, MD, MBA 1092 Transplant Renal Artery or Vein Thrombosis A. Brad Farris, III, MD, MBA 1094 Posttransplant Lymphoproliferative Diseases A. Brad Farris, III, MD, MBA 1104 BK Polyomavirus Neoplasia Evan Farkash, MD, PhD 1106 Protocol Biopsies Lynn D. Cornell, MD and Evan Farkash, MD, PhD 1110 Tolerance Robert B. Colvin, MD 1114 Kidney Xenografts Ivy A. Rosales, MD KIDNEY PATHOLOGY IN RECIPIENTS OF OTHER TRANSPLANTS 1118 Kidney Diseases in Nonrenal Transplant Recipients Robert B. Colvin, MD 1122 Graft-vs.-Host Glomerulopathies Anthony Chang, MD and Yael K. Heher, MD, MPH, FRCP(C) SECTION 10: KIDNEY EXAMINATION 1126 Examination of End-Stage Kidneys Shane Meehan, MB, BCh 1132 Examination of Tumor Nephrectomy Specimens for Nonneoplastic Diseases Kammi J. Henriksen, MD and Stephen M. Bonsib, MD 1136 Evaluation of Transplant Nephrectomies Shane Meehan, MB, BCh and Evan Farkash, MD, PhD 1140 Evaluation of Autopsy Kidneys Kammi J. Henriksen, MD and Mariam Priya Alexander, MD SECTION 11: TECHNIQUES 1146 Basic Concepts for Computational Image Analysis Laura Barisoni, MD and Andrew Janowczyk, PhD 1150 Artificial Intelligence and Digital Pathology Analysis of Kidneys A. Brad Farris, III, MD, MBA 1154 Evaluation of Fibrosis A. Brad Farris, III, MD, MBA 1158 Immunofluorescence on Paraffin Tissue Sections Nidia Messias, MD 1162 EM Processing From Paraffin Tissue A. Brad Farris, III, MD, MBA 1164 Detection of Autoantigens in Membranous Nephropathy Christopher P. Larsen, MD and A. Bernard Collins, BS 1168 Alport Collagen IV Immunofluorescence A. Bernard Collins, BS, Christopher P. Larsen, MD, and Robert B. Colvin, MD 1170 C4d Immunohistochemistry/Immunofluorescence Robert B. Colvin, MD and A. Bernard Collins, BS 1174 Polyomavirus Detection in Tissue Robert B. Colvin, MD 1176 Mass Spectrometry Sanjeev Sethi, MD and Mariam Priya Alexander, MD 1178 Diagnostic Genetics of Kidney Diseases Sanjay Jain, MD, PhD and Yasar Caliskan, MD

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis well-written and the content is clearly presented. There are plentiful figures and tables, which are effectively labeled and adequately support the content. highly recommended for academic and special libraries. effectively presents current research on phytochemicals in a readable manner.- E-Streams This landmark volume shows how far the field has advanced . This important volume is filled with reports on what the editors term as the ''new era'' in the study of phytochemicals, in which we move from the ''eat more vegetable and fruit'' admonition to more detailed information on the biology, molecular biology, regulatory function, and role in human health of phytochemicals. All workers in phytochemicals should get themselves a copy of this valuable book.Table of ContentsNutritional Genomics. Methods to Study Bioavailability of Phytochemicals. Characterization of Polyphenol Metabolites. Microarray Profiling of Gene Expression Patterns of Genistein in Tumor Cells. Gene Regulatory Activity of Ginkgo Biloba L. Cancer Chemoprevention with Sulforaphane, a Dietary Isothiocyanate. Phytochemicals Protect Against Heterocyclic Amine-Induced DNA Adduct Formation. Organosulfur-Garlic Compounds and Cancer Prevention. Polymethylated Flavonoids: Cancer Preventive and Therapeutic Potentials Derived from Anti-inflammatory- and Drug-Metabolism Modifying Properties. Biochemical and Molecular Mechanisms of Cancer Chemoprevention by Tea and Tea Polyphenols. Dietary Flavonoids and Human Cataract Prevention. Phytochemicals and the Prevention of Cardiovascular Disease: Potential Roles for Selected Fruits, Herbs, and Spices. Beneficial Effects of Resveratrol.

Read more less

Book SynopsisLaboratory automation is an increasingly important part of the job description of many laboratory scientists. Although many laboratory scientists understand the methods and principles involved in automation, most lack the necessary engineering and programming skills needed to successfully automate or interface equipment in the lab. A step-by-step, how-to reference and guide, Practical Pharmaceutical Laboratory Automation explores the processes needed to automate the majority of tasks required in research today. The author discusses topics ranging from automated mathematical analysis to robotic automation of chemical processes, to combinations of these and other processes. He presents a detailed discussion of high throughput screening and assay development and takes an in-depth look at Visual Basic as the primary programming language used in laboratories. The text has a dedicated web site (http://www.pharmalabauto.com) that contains all the sample code and examples contained witTable of ContentsIntroduction. Microsoft Excel Visual Basic Macros Running VBA Macros in Excel. Advanced Microsoft Excel VB Macro Techniques. Robotic Automation Using Visual Basic. Low Level Hardware Interfacing Using VB. Electronics for Automation. Robust Data Analysis Using Origin Lab's Origin. Agilent (HP) Chemstation Macro Writing. Appendices.

Read more less

Book SynopsisThis book represents a comprehensive update on pulmonary surfactant by merging classical knowledge with new information. Topics include surfactant secretion and alveolar processing and recycling; physical bases and different theoretical models of the physiological mechanism for pulmonary surfactant action; recent findings on surfactant-like material in other organs; developmental processes and multifactorial regulation; etiology and physiopathology of neonatal respiratory distress; and modern methods for functional explorations of the lung in neonates and experimental models in animals. The book also contains a discussion on the management of hyaline membrane disease, from both the experimental and clinical points of view.Table of ContentsChapter 1 Pulmonary Surfactant — An Overview, Chapter 2 The Type II Pneumocyte, Chapter 3 Nature, Function, and Biosynthesis of Surfactant Lipids, Chapter 4 Structure, Function, and Regulation of Pulmonary Surfactant Proteins, Chapter 5 The Biology of the Surfactant-Associated Proteins, Chapter 6 Comparative Aspects of Pulmonary Surfactant, Chapter 7 Secretion, Alveolar Processing, and Turnover of Pulmonary Surfactant, Chapter 8 Physiological Mechanisms for the Action of Pulmonary Surfactant, Chapter 9 Role of Surfactant in Other Organs, Chapter 10 Developmental Aspects of the Alveolar Epithelium and the Pulmonary Surfactant System, Chapter 11 Fibroblast Pneumonocyte Factor, Chapter 12 Etiology of Neonatal Respiratory Distress Syndrome and the Assessment of Lung Maturity, Chapter 13 Functional Exploration of the Lung in Neonatal Respiratory Distress Syndrome. Use of Animal Models for the Study of Respiratory Distress, Chapter 14 Exogenous Surfactant in the Management of Hyaline Membrane Disease, Index

Read more less

Book SynopsisFibrinolysis in Disease reviews the state of the art of basic and clinical aspects of the fibrinolytic enzyme system. The text, authored by outstanding and internationally known investigators, is presented in two books.The Malignant Process, Interventions in Thrombogenic Mechanisms, and Novel Treatment Modalities discusses the molecular biology of the system''s key components and their fundamental roles in a variety of thrombotic and metabolic disorders. Molecular and Hemovascular Aspects of Fybrinolysis presents the latest findings and concepts of the association between plasminogen activator (u-PA) overexpression and abnormal growth regulation in a variety of solid tumors and in leukemia. One chapter deals with various successful interventions in thrombogenic mechanisms, ranging from exercise and diet to anticoagulants and direct and indirect thrombolytic agents. It concludes with a projection of exciting, novel treatment modalities in thrombotic and malignant diseases.Table of ContentsI. MOLECULAR BIOLOGY OF THE CHIEF REGULATORS OF THE FIBRINOLYTIC/PROTEOLYTIC ENZYME SYSTEMS, Chapter 1. Gene Expression and Function of Tissue Plasminogen Activator, Chapter 2. Structure and Function of the Urokinase-Type Plasminogen Activator Gene, Chapter 3. Gene Expression and Function of Plasminogen Activator Inhibitor-1, Chapter 4. Gene Expression and Function of the Cellular Receptor for u-PA (u-PAR), II. THE ROLE OF THE PLAMINOGEN ACTIVATION SYSTEM IN THE MAINTENANCE OF VASCULAR INTEGRITY, A. General Aspects, Chapter 5. Hepatic Regulation of Fibrinolysis in Normal and Diseased States, Chapter 6. Normal and Abnormal Endothelial Release of t-P A, Chapter 7. Platelets and Fibrinolysis/Thrombolysis, Chapter 8. Lipoprotein(a) and Fibrinolysis, B. Fibrinolytic Abnormalities in Various Disease States, Chapter 9. Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in the Clinical Setting, Including Deep Vein Throm bosis, Chapter 10. Fibrinolysis Factors as Predictors of a Coronary E vent, Chapter 11. The Acute-Phase Reaction of the Fibrinolytic System in Acute Myocardial Infarction and Unstable Angina, Chapter 12. High PAI Activity as an Indicator of Disease Activity in Rest Angina, Chapter 13. High PAI-1 Levels as Marker of Rethrombosis after Successful Coronary Balloon Angioplasty, Chapter 14. Impaired Fibrinolysis in Cigarette Smokers, Chapter 15. Fibrinolysis and Inflammation, Chapter 16. The Fibrinolytic Response to Intravenous Endotoxin Administration, Chapter 17. Prognostic Markers in Septic Shock, Chapter 18. Mechanisms Leading to the Activation of the Fibrinolytic System in Septicemia, Chapter 19. Observations on the Fibrinolytic Response in Two Models of the Baboon in Response to E. coli: Consumptive and Thrombotic Coagulopathies, Chapter 20. Effects of TNF-cc on Endothelial Control of Hemostasis, Chapter 21. Hypercoagulable State in Trauma Patients, Chapter 22. Hypofibrinolysis and Hyperinsulinemia, Chapter 23. Predisposition to Thrombotic Complications in Diabetes Mellitus, Chapter 24. Fibrinolysis and Diabetes Mellitus, Chapter 25. Fibrinolysis and Obesity, Chapter 26. PAI-1 Activity and Serum Lipid Levels, Chapter 27. Hyperfibrinolysis in Liver Cirrhosis, Chapter 28. Hyperfibrinolysis in Liver Transplantation, Chapter 29. Role of Mediators Released by Leukocytes During Liver Transplantation as Possible Contributing Factor for Hyperfibrinolysis and DIC, Chapter 30. Type 1 and Type 2 Plasminogen Activator Inhibitors in Preeclampsia, Chapter 31. Effects of Low-Dose Oral Contraceptives on Fibrinolysis in Teenagers, Chapter 32. Effects of Low-Dose Ethinylestradiol Oral Contraceptives Differing in Progesteron Compound on Coagulation- and Fibrinolytic-Risk Variables for Venous and Arterial Thromboembolic Diseases, Chapter 33. Fibrinolytic Abnormatities and Antiphospholipid Antibodies, Chapter 34. Blood Coagulation and Fibrinolysis in TTP and HUS, Chapter 35. Altered Regulation of Fibrinolysis in Scleroderma and Potential for Thrombolytic Therapy, Chapter 36. Dysregulation of the PA-PAI System in Pulmonary Disease (ARDS and Fibrosis), Chapter 37. Plasminogen Activator Enzymes and Inhibitors in Epithelial Biology and Pathology, Chapter 38. Fibrinolytic Defects in the Cutaneous Vasculitis Atrophie Blanche, INDEX

Read more less

Book SynopsisThis fully updated edition explores the latest techniques to study the challenging, and at times dangerous, genus of bacteria known as mycobacteria with basic methods that are still required for mycobacteriology along with the newer or improved methods that have been developed. The volume features chapters on the basics of DNA isolation, protein isolation, and lipid isolation, as well as more sophisticated techniques for isolation of ribosomes, and continues with sections involving analyzing subcellular fractions, culture methods, sequencing technology, in vitro models, molecular methods, as well as drug discovery applications. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and up-to-date, MTable of Contents1. Culturing Mycobacteria Elizabeth Wallace, Debra Hendrickson, Nicholas Tolli, Carolina Mehaffy, María Peña, Jerry A. Nick, Phillip Knabenbaur, Jackson Watkins, Anne Simpson, Anita G. Amin, Delphi Chatterjee, Karen M. Dobos, Ramanuj Lahiri, Linda Adams, Michael Strong; Max Salfinger, Rebecca Bradford, Timothy T. Stedman, Marco A. Riojas, and Manzour Hernando Hazbón 2. DNA Isolation from Mycobacteria Heena Jagatia and Daire Cantillon 3. Extraction and Separation of Mycobacterial Proteins Megan Lucas, Joan M. Ryan, Jackson Watkins, Kala Early, Nicole A. Kruh-Garcia, Carolina Mehaffy, and Karen M. Dobos 4. Lipid and Lipoarabinomannan Isolation and Characterization Marie-Antoinette Lanéelle, Lucie Spina, Jérôme Nigou, Anne Lemassu, and Mamadou Daffé 5. Purification of Hibernating and Active C- Ribosomes from Zinc-Starved Mycobacteria Yunlong Li, Pooja Keshavan, Jamie H. Corro, Ravi K. Koripella, Rajendra K. Agrawal, and Anil K. Ojha 6. Macrophage Infection Models for Mycobacterium tuberculosis Benjamin K. Johnson, Sean M. Thomas, Andrew J. Olive, and Robert B. Abramovitch 7. Novel Single-Cell and High Throughput Microscopy Techniques to Monitor Dictyostelium discoideum-Mycobacterium marinum Infection Dynamics Manon Mottet, Cristina Bosmani, Nabil Hanna, Jahn Nitschke, Louise Lefrancois, and Thierry Soldati 8. Single-Cell Analysis of Mycobacteria Using Microfluidics and Time-Lapse Microscopy Giulia Manina and Neeraj Dhar 9. Measuring Efflux and Permeability in Mycobacteria Liliana Rodrigues, José A. Aínsa, and Miguel Viveiros 10. Drug Susceptibility Screening Using In Vitro Models of Hypoxic Non-Replicating Persistent Mycobacteria Savannah E.R. Gibson, James Harrison, and Jonathan A.G. Cox 11. Flow Cytometry Analysis of Mycobacteria and Mycobacteria-Infected Immune Cells Sydney L. Solomon and Bryan D. Bryson 12. Electroporation of Mycobacteria Tanya Parish 13. Gene Switching and Essentiality Testing Amanda Claire Brown 14. Oligo-Mediated Recombineering and Its Use for Making SNPs, Knockouts, Insertions, and Fusions in Mycobacterium tuberculosis Kenan C. Murphy 15. Using Proteolytic Hypomorphs to Detect Small Molecule Mechanism of Action Eachan O. Johnson and Deborah T. Hung 16. CRISPR Interference (CRISPRi) for Targeted Gene Silencing in Mycobacteria Andrew I. Wong and Jeremy M. Rock 17. Exploiting Fluorescent Proteins to Understand Mycobacterium tuberculosis Biology David Giacalone, Lu Huang, and Shumin Tan 18. Metabolic Labeling of Live Mycobacteria with Trehalose-Based Probes Nicholas Banahene and Benjamin M. Swarts 19. Identification and Characterization of Mycobacterial Species Using Whole Genome Sequences Marco A. Riojas, Andrew M. Frank, Samuel R. Greenfield, Stephen P. King, Conor J. Meehan, Michael Strong, Alice R. Wattam, and Manzour Hernando Hazbón 20. Whole Genome Sequencing of Mycobacterium tuberculosis Directly from Sputum Samples Amanda Claire Brown 21. Experimental and Computational Workflow for RNA Sequencing in Mycobacterium tuberculosis: From Total RNA to Differentially Expressed Genes Shuyi Ma, Richard M. Jones Jr., Natalie S. Gleason, Jessica Farrow-Johnson, and David R. Sherman 22. RNA Sequencing for Transcript 5′-End Mapping in Mycobacteria M. Carla Martini, Huaming Sun, and Scarlet S. Shell 23. Methods for Proteomic Analyses of Mycobacteria Carolina Mehaffy, Megan Lucas, Nicole A. Kruh-Garcia, and Karen M. Dobos 24. Targeted Lipidomics of Mycobacterial Lipids and Glycolipids Emilie Layre 25. Metabolomics of Mycobacterium tuberculosis Kyle A. Planck, Madhumitha Nandakumar, Luiz Pedro S. de Carvalho, and Kyu Rhee 26. Determining Minimum Inhibitory Concentrations in Liquid Cultures or on Solid Medium Qinglan Wang and Helena I.M. Boshoff 27. A Multi-Stress Model for High Throughput Screening Against Non-Replicating Mycobacterium tuberculosis Ben Gold, Thulasi Warrier, and Carl Nathan 28. Antimicrobial Susceptibility Testing for Mycobacterium sps in High Throughput Format Esther Pérez-Herrán and Alfonso Mendoza 29. High-Content Analysis Monitoring Intracellular Trafficking and Replication of Mycobacterium tuberculosis Inside Host Cells Nathalie Deboosere, Imène Belhaouane, Arnaud Machelart, Eik Hoffmann, Alexandre Vandeputte, and Priscille Brodin 30. Efficient Measurement of Drug Interactions with DiaMOND (Diagonal Measurement of N-Way Drug Interactions) Nhi Van, Yonatan Degefu, and Bree B. Aldridge 31. Drug Sensitivity Testing of Mycobacterium tuberculosis Growing in a Hollow Fiber Bioreactor Brett Mason and Véronique Dartois

Read more less

Book SynopsisIncidences of inflammatory airway diseases are on the rise across the world. Existing therapeutic options are ineffective, unsafe, and expensive, and severe cases are nonresponsive to conventional therapy. Therefore, it is imperative that research be undertaken to discover new treatment options. Obstructive Airway Diseases: Role of Lipid Mediators discusses clinically successful and potential lipid targets that can make a difference in treating some of the most intractable disease states.Topics discussed include: Obstructive airway diseases, etiology, pathophysiology, and existing therapeutic options What constitutes a lipid and how it is broken down to generate biologically active mediators The role of enzymes in the process of lipid mediator synthesis The biology of arachidonic acid, platelet-activating factor, and lysophosphatidic acid and the role they play in airway inflammation Products of aracTable of ContentsObstructive Airway Diseases: Epidemiology, Etiology, and Therapeutic Options. Lipids: Reservoir of Drug Targets. Phospholipase A2 as a Potential Drug Target for Airway Disorders. 5-Lipoxygenase Pathway: A Validated Route to Drug Discovery. Leukotriene Receptor Antagonists and FLAP Inhibitors. EETs and Oxo-ETE in Airway Diseases. The Eosinophil Chemoattractant 5-Oxo-ET. Cyclooxygenases and Prostaglandin Receptors. Proresolution Mediators of Inflammation in Airway Diseases: Resolvins Pave New Directions. Platelet-Activating Factor Antagonist Therapy for Airway Disorders. Lysophosphatidic Acid in Airway Inflammation. Sphingolipids in Airway Inflammation. Protein Kinase C Isozymes and Airway Inflammation. Prospects for PI3 Kinase Signaling Inhibition in Obstructive Airway Diseases. Index.

Read more less

Book SynopsisThis book provides a practicable framework for standardized histopathology reports. It includes the 7th edition TNM and WHO classifications of cancers and explains key epidemiological, clinical, investigative, pathological, prognostic and treatment issues.Trade ReviewFrom the reviews of the third edition:“Dr Allen’s book … aims to ‘equip the consultant and trainee pathologist with a summary of the key clinical, pathological and scientific knowledge relevant to any particular cancer type, with the safeguarding of consistent and high quality histopathology reports’. … This is an invaluable desk book for all histopathologists, whether they are just starting out in their careers or are well-established specialists.” (Abbie Pugh, Bulletin of the Royal College of Pathologists, Vol. 166, April, 2014)“This book briefly describes the correct reporting of various surgical cancer specimens according to current published standards. The purpose is to equip pathologists to report on surgical cancer specimens in a timely, accurate, and reproducible manner. … Residents and practitioners of pathology are the intended audience. … The best aspect of the book is the consistent format it uses throughout, which allows for rapid referencing when a reporting question arises in practice. … It also has helpful pictures demonstrating the proper staging of a specimen.” (James W. Bush, Doody’s Book Reviews, January, 2014)Table of ContentsIntroduction.- Gastrointestinal Cancer: Oesophageal Carcinoma.- Gastric Carcinoma.- Ampulla of Vater and Head of Pancreas Carcinomas.- Small Intestinal Carcinoma.- Colorectal Carcinoma.- Vermiform Appendix Tumours.- Anal Canal Carcinoma (with Comments on Pelvic Exenteration).- Gall Bladder Carcinoma.- Extrahepatic Bile Duct Carcinoma.- Liver Carcinoma.- Head and Neck Cancer: General comments.- Lip and Oral Cavity Carcinomas.- Oropharyngeal Carcinoma (with comments on Nasopharynx and Hypopharynx).- Nasal Cavity and Paranasal Sinus Carcinomas.- Laryngeal Carcinoma.- Salivary Gland Tumours.- Thyroid Gland Tumours (with comments on Parathyroid).- Respiratory and Mediastinal Cancer: Lung Carcinoma.- Malignant Mesothelioma.- Mediastinal Cancer.- Skin Cancer: Non-Melanocytic Skin Carcinoma.- Malignant Melanoma.- Breast Cancer: Breast Carcinoma.- Gynaecological Cancer: Ovarian Carcinoma (with comments on Fallopian Tube Carcinoma).- Endometrial Carcinoma.- Cervical Carcinoma.- Vaginal Carcinoma.- Vulval Carcinoma.- Gestational Trophoblastic Tumours.- Urological Cancer: Renal Cell and Renal Pelvis/Ureter Carcinomas.- Bladder Carcinoma.- Prostate Carcinoma.- Urethral Carcinoma.- Testicular Cancer.- Penile Carcinoma.- Lymph Node Cancer: Nodal Malignant Lymphoma (with comments on Extranodal Malignant Lymphoma and Metastatic Cancer).- Bone and Soft Tissue Cancer: Bone and Soft Tissue Sarcomas (with comments on Retroperitoneum and Adrenal Gland).- Ophthalmic Cancer: Intraocular Malignancy.- Extraocular Malignancy.

Read more less

Book SynopsisPart of the highly regarded Biopsy Interpretation Series, this new volume by Drs. Laura M. Wake, Genevieve Crane, and Michael Borowitz presents a concise, pattern-based approach to bone marrow pathology. Biopsy Interpretation of the Bone Marrow provides superbly illustrated guidance from top experts in the field, covering all aspects of bone marrow aspirates and biopsies: procurement and processing, ancillary techniques, formulation of a final diagnosis, and reporting to the clinical team. Hundreds of full-color illustrations depict the full range of benign and neoplastic processes involving the bone marrow.  Presents information in an easily accessible, consistent format with concise text, high-resolution color photomicrographs, and full-color diagrams and illustrations to clarify key concepts  Uses algorithms and concept maps wherever possible to visually summarize complex relationships  Focuses on practical,

Read more less

Book SynopsisDermatopathology Primer of Cutaneous Tumors presents a detailed overview of the most common skin neoplasms. For each neoplasm, the epidemiology, pathophysiology, clinical features, clinical variants, and special studies are presented in a succinct, bulleted form. Extensive illustrations demonstrate each neoplasm's characteristic features, as well as those of other tumors in the histological differential. The book covers both benign and malignant cysts, epidermal, melanocytic, lymphoid, and soft tissue neoplasms. It complements the Dermatopathology Primer of Inflammatory Diseases, written by authors of the same team. These books introduce the basic concepts of dermatopathology to medical students and residents training in pathology and dermatology as well as to other health care professionals seeking a resource for a basic understanding of dermatopathology.Offered in an easy-to-read format, the book provides a basic understanding of dermatTable of ContentsTumors of the Epidermis. Benign Tumors. Malignant Tumors. Melanocytic Neoplasms. Benign Neoplasms. Malignant Lesions. Tumors of Cutaneous Appendages. Hair Follicle Tumors. Sebaceous Tumors. Sweat Gland Neoplasms. Tumors of Fibrous Tissue. Benign Tumors. Malignant Tumors. Tumors of Fat. Lipoma. Angiolipoma. Nevus Lipomatosus. Tumors of Smooth Muscle. Benign Neoplasms. Malignant Tumors. Neural Tumors. Nerve Sheath Tumors. Vascular Tumors. Hyperplasias. Benign Neoplasms. Malignant Tumors. Cutaneous Cysts. Epidermal Cyst. Pilar Cyst. Dermoid Cyst. Steatocystoma. Bronchogenic Cyst. Cutaneous Ciliated Cyst. Median Raphe Cyst. Cutaneous Metastases. Cutaneous Metastases. Cutaneous Infiltrates, Non Lymphoid. Mast Cell Infiltrates. Histiocytic Infiltrates. Neuroendocrine Infiltrates. Cutaneous Infiltrates, Lymphoid and Leukemic. Pseudolymphomas. Cutaneous Lymphomas. Leukemic And Miscellaneous Infiltrates.

Read more less

Book SynopsisIn keeping with the spirit of the first edition, the second edition of this book displays the autopsy procedure in a step-wise, start-to-finish fashion. While the autopsy itself has changed little over the last 100 years, the adjunct procedurestoxicology, radiology, and DNA analysis, among othershave changed greatly. Original chapters are fully updated and modified to reflect changes in the last 15 years. Additionally, two new chapters have been added on natural death and organ/tissue donation.Table of ContentsApproach to the Autopsy. Circumstantial and Medical History. External Examination: The Preliminary Examination. External Examination, Specific Forensic Injuries. Specific Body Areas. Internal Examination: Opening of Body Cavities and Initial Assessment. Organ and Tissue Removal. Individual Organ Examination. Head, Brain, Skull and Spinal Cord. Microscopic Examination. Postmortem Laboratory Analysis. Natural Death. Organ and Tissue Donation.

Read more less

Book SynopsisThis book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.Trade ReviewFrom the reviews:“This is a comprehensive overview of biomarkers as they relate to pathogenesis and clinical utility in the diagnosis, staging, and treatment of melanoma. … The audience is practitioners specializing in melanoma, including dermatologists, surgeons, and oncologists, as well as researchers in the field. … book broadly explores the role of molecular diagnostic techniques and specific biomarkers which may serve to facilitate more accurate diagnoses and identify early-stage melanoma patients with high risk for metastasis. … I highly recommend this book for melanoma clinicians and researchers.” (Susan M. Swetter, Doody’s Book Reviews, July, 2012)Table of ContentsTable of Contents:1. Introduction to Diagnostic and Prognostic Biomarkers and Therapeutic Targets in MelanomaMichael J. Murphy2. Diagnostic and Prognostic Biomarkers in Melanoma: Current State of Play Jochen Utikal, Jürgen C. Becker, and Selma Ugurel3. Molecular Pathogenesis of Melanoma: Established and Novel PathwaysPaolo Antonio Ascierto, Maria Libera Ascierto, Mariaelena Capone, Zendee Elaba, Michael J. Murphy, and Giuseppe Palmieri4. Staging of MelanomaZendee Elaba, Michael J. Murphy, Philip Kerr, and Jane M. Grant-Kels 5. Clinical and Histopathological Parameters in MelanomaCheryl Bilinski, Avery LaChance, and Michael J. Murphy6. Genetic/Epigenetic Biomarkers: Distinction of Melanoma from Other Melanocytic NeoplasmsMinoru Takata 7. mRNA Biomarkers in MelanomaGiovanna Chiorino and Maria Scatolini8. Epigenetic Biomarkers in MelanomaSuhu Liu, Suping Ren, Paul M. Howell Jr., and Adam I. Riker9. microRNA Biomarkers in MelanomaJim Kozubek, Faseeha Altaf and Soheil S. Dadras10. MicroRNAs as Biomarkers and Therapeutic Targets in MelanomaDaniel W. Mueller, Anja K. Bosserhoff11. Mitochondrial DNA Biomarkers in MelanomaMark L. Steinberg12. Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (A) DiagnosisSteven J. Ohsie, Basil A. Horst, Alister Cochran, and Scott W. Binder13. Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (B) PrognosticationBasil A. Horst, Steven J. Ohsie, Alister Cochran, and Scott W. Binder14. Tissue-Based Protein Biomarkers in Melanoma: Mass Spectrometry-Based StrategiesMichael J. Murphy, Karim Rezaul, and David K. Han15. Serological Biomarkers in MelanomaMel Ziman, Michael Millward, Robert Pearce, and Mark Lee16. Molecular Markers of Lymph Node Disease in MelanomaSandro Pasquali, Augustinus P.T. van der Ploeg, and Simone Mocellin17. Melanoma Cell Propagation: Cancer Stem Cell, Clonal Evolution and Interconversion Models of TumorigenicityQiuzhen Liu, Marianna Sabatino, David F. Stroncek, Ping Jin, Francesco M. Marincola, and Ena Wang 18. Surgical Management of Melanoma: Concept of Field Cancerization and Molecular Evaluation of Tissue MarginsAmanda Phelps and Michael J. Murphy19. Chemotherapy for MelanomaHedwig Stanisz, Thomas Vogt, and Knuth Rass20. Molecular-Targeted Therapy for MelanomaAlessia E. Russo, Ylenia Bevelacqua, Andrea Marconi, Andrea Veronesi, and Massimo Libra21. Anti-Angiogenesis Therapy for MelanomaRoberta Ferraldeschi and Paul Lorigan22. Immunological Biomarkers and Immunotherapy for MelanomaJochen T. Schaefer23. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma: An OverviewAhmad A. Tarhini and John M. Kirkwood

Read more less

Book SynopsisPersonality Disorder (PD) is one of the most difficult psychological conditions to classify and treat and in the past literature on the subject has tended to neglect the invaluable viewpoint of sufferers themselves. Drawing on extensive research carried out in conjunction with service users, Heather Castillo seeks to adjust this imbalance and looks at the classification and treatment of PD from the service users' viewpoint. This book emphasises the need for health professionals to reassess their approach to the condition and allows those with PD to effectively define themselves and their illness. With a wide range of case study material and analysis, this book is essential reading for mental health professionals, workers in the voluntary and forensic sectors and service users themselves.Trade ReviewThis is a good book about personality disorder, which is also a great book about advocacy... Vividly is to convey, in people's own words, what it feels like to have the label `personality disorder', and points us towards a new understanding of both this term and other diagnoses, which includes the personal experience, as well as the theoretical framework of `the helper'... At it's best advocacy has been a vehicle to help articulate the views of people generally not heard. This book is a perfect example of this, and in a time when advocacy is changing, we should cherish Castillo's book as example of a kind of advocacy that may be going out of fashion... Her book is an attempt to redress that failing, and despite the nightmarish descriptions, the overall impression we are left with is hopeful and, yes, emancipatory - partly because Castillo has succeeded in throwing some light into a corner of the world most of us find hard to look at. -- Psychotherapy & Politics InternationalIf there ever was a book that would turn the conventional, conservative view of personality disorder on its head, this is it. The book is presented in an easily readable form, with a comprehensive background to the subject of personality disorder at start, then the methodology of the study, then the results presented in a meaningful way. The discussion that follows is colourfully illustrated with quotes and examples of service user poetry and creative writing that are often shocking and always moving. This book wisely tells us that we can overcome a difficult disorder by thinking differently, and gives us a way forward. Very welcome in any service that is forward thinking, enlightened and wanting to find new ways to help their service users. -- Journal of Mental HealthThe book looks at the history of personality disorder diagnosis, and the difficulties and limitations in classifying people in this way...The research process and findings are informative and inspirational. The involvement of the researchers in the task contributed to their individual recovery, and the book offers an invaluable contribution to our understanding of personality disorder. -- Community CareIt is an exciting and interesting book and I would recommend it to anybody who wants to know about what it is like to live with the diagnosis of personality disorder and what others can do to help. It is a n excellent example of how we can use research to provide a platform for voices from the margins and to help service users use the power that comes from knowing something from the inside out. -- Counselling and Psychotherapy JournalAn insight into the trauma behind the behaviour to (hopefully) inform future service development. -- Mental Health TodayTable of Contents1. Dreaming of a better way. 2. A Historical perspective. 3. The disliked patient. 4. Personality development. 5. Complex post traumatic syndrome. 6. Treatability. 7. Is suffering an illness? 8. Getting our act together. 9. The task. 10. Demographics and themes. 11. What personality disorder means to us. 12. Experiences. 13. The moral career of the client. 14. The diagnostic straightjacket. 15. Spreading the word. 16. New beginnings. Index.

Read more less

Book SynopsisAs a psychodynamic theory of both normal development and psychopathology, attachment theory has particular utility for forensic psychiatry. A Matter of Security provides an attachment theory based account of the development of arousal and affect regulation, which offers a new way of thinking about mental disorders in offenders. This book also discusses the development of personality in terms of interpersonal functioning and relationships with others, which is essential to understanding both interpersonal violence and abnormal personality development. Attachment theory also offers a model of therapeutic work with patients that have particular resonance with forensic work because it uses the language of security. This collection focuses on attachment theory applied to forensic psychiatry and psychotherapy.Trade ReviewThis is a fascinating book which will be of interest to those concerned with forensic contexts. It combines theoretical and practical content and provides an excellent source of literature for further reading. This is a book at the frontier of knowledge in a specific domain that offers a useful first source for thinking about how attachment theory can be applied in forensic situations. -- Journal of Interprofessional CareA Matter of Security is an invigoration collection of essays in which attachment theory is used as a framework to explore a variety of issues in forensic psychiatry. The variety of content and methodologies makes A Matter of Security an invaluable resource for anybody working in or thinking about forensic psychiatry. -- Metapsychology Online Book ReviewsThis book is a `must read' for all clinicians working in forensic psychiatry. It explores the psycho-dynamic theory of attachment and ways in which this theoretical base can be used to offer new ways of thinking about, and working therapeutically with, mental disorders in offenders. The authors of the various chapters represent a wide range of disciplines from a variety of forensic settings, demonstrating the flexibility of this theoretical framework. -- Mental Health PracticeTable of ContentsForeword, Friedemann Pfäfflin, University of Ulm and Gwen Adshead, Broadmoor Hospital. Part I: Theory. 1. The Developmental Roots of Violence in the Failure of Mentalization, Peter Fonagy, University College London. 2. Attachment Representation, Attachment Style or Attachment Pattern? Usage of Terminology in Attachment Theory, Thomas Ross, University Clinic of Ulm. 3. Fragmented Attachment Representations, Franziska Lamott, University of Ulm, Elisabeth Fremmer-Bombik, Hospital for Child and Youth Psychiatry in Regensburg and Friedemann Pfäfflin. Part II: Clinical Issues 4. The Link Between Childhood Trauma and Later Violent Offending: The Application of Attachment Theory in a Probation Setting, Paul Renn, Centre for Attachment-based Psychoanalytic Psychotherapy. Part III: Institutional Issues. 5. Three Degrees of Security: Attachment and Forensic Institutions, Gwen Adshead. 6. Forensic Mental Health Nursing: Care with Security in Mind, Anne Aiyegbusi, Broadmoor Hospital. 7. Finding a Secure Base: Attachment in Grendon Prison, Michael Parker, HMP Grendon and Mark Morris, The Portman Clinic. Part IV: Research Data. 8. Attachment Representations and Factitious Illness by Proxy: Relevance for Assesment of Parenting Capacity in Child Maltreatment, Gwen Adshead and Kerry Bluglass, The Woodbourne Clinic. 9.Violence and Attachment: Attachment Styles, Self-regulation and Interpersonal Problems in a Prison Population, Thomas Ross, University Clinic of Ulm and Friedemann Pfäfflin. 10. Attachment Representations and Attachment Styles in Traumatized Women, Franziska Lamott, University of Ulm, Natalie Sammet, cognitive behavioural psychotherapist and Friedemann Pfäfflin, University of Ulm. Conclusion: A Matter of Security. Friedemann Pfäfflin and Gwen Adshead. Subject Index. Author Index.

Read more less

Book SynopsisSelf-harm in adolescence and late teens is known to be increasing, though it is difficult to detect and inconsistently recorded. This thorough, practical and evidence-based book provides guidance for professionals and parents caring for children and young people at risk of self-harm and suicide.Claudine Fox and Keith Hawton discuss risk factors for self-harm, including depression, substance abuse and antisocial behaviour, and critically examine key screening instruments that can be used to assess risk. They describe how suicidal behaviour can be managed and prevented, and look at the effectiveness of aftercare treatment for those who self-harm, including school-based suicide-prevention programs and family therapy. Also addressed are common myths about self-harm and the problem of varying definitions in this field.Deliberate Self-Harm in Adolescence clearly summarizes and evaluates current research into suicidal behaviour - it is essential reading for social workers, mental health professionals, GPs, teachers and parents.Trade ReviewDeliberate Self-Harm in Adolescence addresses the seriousness and importance of the issue of self-harming behaviour in adolescence, and in particular the pressing need for awareness and research. The publication provides rigorous current research and an associated understanding of a number of issues relating to self - hard and more particularly suicide. Commissioned by FOCUS, a child and adolescent mental health project which aims to promote evidence based practice through the dissemination of information, the book reviews existing literature, critically appraises current research and ultimately establishes a knowledge based and practice base regarding self-harming and suicidal behaviour. -- Journal of Interprofessional CareThis book covers the major issues surrounding risk factors, tools for identifying those adolescents at risk, service management and preventive measures… the book is well written, with a clear style and layout, occasionally illustrating the test with quotes and providing a brief summary of at the end of each chapter… This is an interesting book written primarily for practitioners and those undertaking research in the field'. -- Child & Family Social WorkSelf-harm during adolescence is known to be on the increase. The authors of this book broker policy and evidence based practice and translated this into practical suggestions for the mental health professionals. -- Mental Health PracticeThis book would be particularly useful to people in the academic world, specialists in mental health, practitioners and policy makers- It has useful pointers to key models and research. -- 0-19 Magazinea useful and thorough grounding in the subject for a wide variety of health and social care professionals, and for parents or carers. -- Care and Health MagazineTable of ContentsAcknowledgements. Preface. 1. Introduction. 2. The prevalence of suicidal behaviour in adolescence. 3. Risk factors for adolescent suicidal behaviour. 4. Identifying at-risk adolescents. 5. Services for adolescents. 6. The outcome of suicidal behaviour in adolescence. 7. Managing adolescent suicidal behaviour. 8. Preventing adolescent suicidal behaviour 9. Future prospects. Resources. Appendix. References. Indexes. About FOCUS.

Read more less

Book SynopsisWidely regarded as the definitive work on forensic psychotherapy, this major compendium is now also published in paperback in one volume.This compendium of forensic psychotherapy brings together the contributions of over sixty authors and covers all aspects- both theoretical and applied- of this currently crystallizing field.Trade ReviewThe book's coverage of psychic processes and their effect on inner and outer world phenomena mark its importance for all who are involved with difficult patients or clients. It is the first major book on forensic psychotherapy marking a developmental milestone in this speciality. It is therefore a must for libraries and any institution or organization, which involves itself practically or academically with offender patients. It has immense personal appeal...written in a style that conveys respect and a sensitivity for the patient and their difficulties. The many areas incorporated in this book mean that there is always something, which resonates with the various wishes and expectations of the reader, whether they be theoretical or mainly practical. The ability of this text to intellectually stimulate and make emotional contact with the reader is only rivaled by its potential to impart knowledge. -- IAFP NewsletterA welcome reminder of how important the psycho-therapeutic aspect is in the forensic-psychiatric patient's treatment during both hospital and outpatient treatment... Forensic Psychotherapy gives the basic knowledge to understand the offender's psychological traumas and their association with violent behavior... Having this book, the reader will be convinced that as a forensic psychiatry worker his goal is not only to minimize criminal behavior but also to maximize the offender's quality of life, irrespective of the type of crime committed. Forensic Psychotherapy provides the reader with an impressive array of information, and we recommend it to all interested professionals. -- The LancetThe book's coverage of psychic processes and their effect on inner and outer world phenomena mark its importance for all who are involved with difficult patients or clients. It is the first major book on forensic psychotherapy marking a developmental milestone in this speciality. It is therefore a must for libraries and any institution or organisation which involves itself practically or academically with offender patients. It has immense personal appeal...written in a style that conveys respect and a sensitivity for the patient and their difficulties. The many areas incorporated in this book mean that there is always something which resonates with the various wishes and expectations of the reader, whether they be theoretical or mainly practical. The ability of this text to intellectually stimulate and make emotional contact with the reader is only rivaled by its potential to impart knowledge. -- Therapeutic Communities (The International Journal for Therapeutic and Supportive Organisations)Table of ContentsAcknowledgements. Caveat. Foreword by John Gunn, CBE, Professor of Forensic Psychiatry, Institute of Psychiatry. Foreword by Richard Wells, Chief Constable, South Yorkshire Police. Preface: In and Out of the Mind, The Editors. Volume 1. Mainly Theory. Introduction. The Criminal Act and Acting Out.

Read more less

Book SynopsisPrison Theatre describes the rich variety of programmes of theatre with offenders. This multi-disciplinary volume informs debates both in the criminal justice system and in discussion about the role and function of theatre. The contributors explore a wide range of topics within this diverse field, including:- working with women prisoners and with people with learning difficulties- dramatherapy with violent offenders- prison theatre work in Brazil- theatre work with young offenders- dramatic intervention in probation services and with ex-offenders. This is a stimulating and thought-provoking book which will provide valuable reading for practitioners, professionals and students across the fields of the arts therapies, criminology and criminal justice, psychology and performing arts.Trade ReviewThe 13 chapters in this books are serious, thoughtful and varied. The particular problems of prison work are spelled out meticulously. The essays are not only useful for prison work. There are very generous outlines of processes which could be stimulating for other groups. -- New LifeThis book has changed my life. Soon after I received it ... the University of Turin launched a scheme to begin offering courses in local prisons. They wanted someone to teach an English course. Stirred by the book, I showed interest - and was accepted ... The 13 chapters in the book are serious, thoughtful and varied. The particular problems of prison work are spelled out meticulously ... The essays in this book are not useful only for prison work. There are very generous outlines of processes which could be stimulating for other groups too ... I welcome the 'Forensic Focus' series. This, in particular, is a very stimulating and valuable book. Go easy with it. It may change your life. -- DramatherapyPrison Theatre... offers a variety of perspectives on a range of practical and theoretical approaches to the use of drama and theatre in prisons and probation. Although mostly about the criminal justice system in Britain the work undertaken in Brazilian prisons gives examples of working practices and a positive commitment to work in the arts in prisons that could be studied further in this country. Particularly interesting and useful are the four chapters which deal with the therapeutic and rehabilitative aspects of using drama and theatre in secure settings including the use of creative processes to examine the roots of offending behaviour and in building prisoners' confidence, self-esteem and communication skills. The practices described in this book challenge the 'deeply reactionary notion that punishment has any significant determining effect on crime' (p. 40). The preface to each section, by an American who is now serving a life sentence without the chance of parole, and the chapter by Joe White (an ex-offender, now a playwright and director) offer ample evidence of the powerful and positive effect of this kind of work. An over-arching focus within the whole publication is the overlap between work in drama and theatre and the links between therapy, education and rehabilitation. It is clear that a hybrid form of practice is being developed in this particular context which is worthy of further in-depth study. -- Speech & DramaTable of ContentsAcknowledgements. Introduction James Thompson. Part One: Questioning the Practice. Preface Victor Hassine. 1. Theatre, Prisons and Citizenship: A South American Way Paul Heritage. 2. Resistence and Expression: Working with Women Prisoners and Drama Jenny Hughes. Part Two: Therapy and Rehabilitation. Preface Victor Hassine. 3. Treading on Tails: Telling all Stories Pauline Gladstone and Angus McLewin. 4. Holding On: Dramatherapy with Offenders Sally Stamp. 5. The House of the Four Rooms: Theatre, Violence and the Cycle of Change Alun Mountford and Mark Farrell. 6. Twisting Paradoxes Chris Johnston. Part Three: Working in the Institution. Preface Victor Hassine. 7. Creating Drama through Advanced Improvisation in Prisons Rob Clare. 8. `Silent Voices': Working with Black Male Inmates - A Perspective Martin Glynn. 9. The Prisoner's Voice Joe White. 10. Drama and the Institution Anne Peaker. 11. Shakespeare and Broadmoor: Timelessness Updated Murray Cox. Part Four: Evaluation and History. 12. Evaluating Theatre in Prisons and Probation Michael Balfour and Lindsey Poole. 13. Rebellion and Theatre in Brazilian Prisons: An Historical Footnote Paul Heritage. List of Useful Addresses. The Contributors. Indices.

Read more less

Book SynopsisThis book consists of a series of assessments designed for professionals working with mentally disordered offenders and clients with challenging behaviours. It is written for psychiatrists, psychologists, nurses, social workers, probation officers and professionals involved in court diversion schemes and is for use both before and after admission. Clearly laid out, and taking a holistic approach, each section focuses on a specific topic, giving the practitioner a tool that will capture essential and relevant information and enabling care teams to develop a comprehensive and consistent management strategy. Comprehensive in scope, users can select from the more specific sections those appropriate for use with particular clients. Forensic issues are covered as well as those for general use. This is a practical and user-friendly book; it contains the detail to ensure an accurate, objective assessment and is designed to adapt to each user's particular needs. The format allows and encourages additions to give a complete picture of the individual. Already extensively tested, this material is in current use.Trade Review`an excellent tool with which to assess mentally disordered offenders and those with challenging behaviours in pre- and post-admission situations The holistic and clear manner affords the practitioner the opportunity to select from a number of individual assessments tailored to the needs of a particular clientthe format is all-embracing and user-friendly. Each assessment incorporates enough detail to provide the practitioner with a thorough and impartial framework with which to assist the clientthey allow the practitioner to develop and extend on the particular assessment to give a fuller picture of the client. Overall this is a very useful and comprehensive publication.' -- Professional Social WorkTable of ContentsAuthors acknowledgements. Foreword. Instructions for use. 1. Basic care issues. 2. Medical history. 3. Incident history. 4. External network. 5. Behaviour at night. 6. Life experiences. 7. Security issues. 8. Previous placements/treatments. 9. Significant events. 10. Social behaviour. 11. Recreational activities. 12. Threat/fantasy issues. 13. Sexual issues. 14. Loss/Bereavement. 15. Self harming behaviours. 16. Hostage taking history. 17. Eating issues. 18. Arson. Appendix.

Read more less

Book SynopsisThe contributors to this wide-ranging volume are experts from a range of psychiatric, criminal justice, legal and ethical backgrounds, and, uniquely, include patients who recount their own experience of forensic care settings. They examine and explore the central theoretic issues, such as culture, power, difference and participation, and relate them to examples of current practice, and to the improvement of future service provision. They identify techniques and approaches which will improve care and treatment.Race, Culture and Ethnicity in Secure Psychiatric Practice: Working with Difference. provides essential information and analysis which exposes society's view of minorities and the influence these views may have on care professionals working in psychiatric and criminal justice systems. It suggests practical steps for improvement to ensure a more equitable and culturally sensitive service provision.Trade ReviewIts mixture of essays and poetry intersperses the personal and the political, and in so doing helps to underscore the rich and multi-layered issues that frame black and minority ethnic people's lives -both in the mental health system and more broadly...Its not a moment too soon. -- Transcultural SocietyI would encourage forensic practitioners to read this book. It contains some outstanding individual contributions, answers to specific cultural questions and provides resources to help address racial issues in secure services, in the form of policy statements and audit protocols from Broadmore Hospital. -- British Journal of PsychiatryThis book addresses issues such as anti discriminatory training, diet, religious and spiritual needs. These are not addressed in a practical sense in most psychiatric secure units, and it is commendable that they are covered in this book. The editors also deal with an unprecedented, though very much welcomed, area; the experience of black staff at work. This is one of the most controversial issues in nursing generally. There were no attempts by the editors to water down the grim reality of the situation as experienced by many black staff at work. The discussion on racism from patients must also be singled out. All too often, those who are in a position to make a difference dance nervously around this issue. It is a relief to see this book addressing the problem and making suggestions to bring about change...I hope that this book will help health professionals to find a way through this hummocky terrain. -- Nursing TimesIts strength lies in two areas. The first is the editor's ability to have assembled a number of different voices. This aids its overall impact and helps to drive home the message that focusing on race, culture and ethnicity should be on everyone's agenda - not least consultant psychiatrists ...The second point worth noting is the books' accessibility. Its mix of essays and poetry intersperses the personal and the political. This helps to underscore the rich and multi-layered aspects which frame black and minority ethnic people's lives - in the mental health system and more broadly. -- Health Service JournalKaye and Lingiah have done justice to this most difficult of issues facing secure psychiatric services. The justice concerns the three main aspects of this book. The first relates to the way the contributors approach their topic, in a bright, refreshing yet serious manner that adds a "newness" to the debate. Second, they do not shirk the sensitive issue of the relationship between cultural difference and societal expectations. Rather than simply laying blame for failings, the contributors discuss the issues of causation in a thoughtful and provocative way. Third, they attempt to provide some suggestions as to how we may begin to address the problems of prejudice in forensic practice, and these suggestions are practical and realistic.The editors should be applauded for producing such a well structured and meaningful text that focuses fresh attention on a longstanding problem. The structure is logical, dealing first with structures and power relating to the notion of difference and moving on to cover ways of achieving a better balance via change and development.' -- Mental Health CareTable of ContentsPart I: Structures and Power 1.The Beginning of the Journey, Charles Kaye, Former Chief Executive, SHSA. 2. Awareness and Change, Charles Kaye, Former Chief Executive, SHSA. 3. Mental Healthn Black and Ethnic Minorities: An Epidemiological Perspective, Veena Soni Raleigh, University of Surrey . 4. `Race', Criminality and Forensic Psychiatry: A Historical Perspective, Suman Fernando, Tizard Centre. 5. Differences in Ritual and Culture, Quintin Deeley, Maudsley Hospital. 6. Racism and the Expression of Identity in Special Hospitals, Annie Bartlett, Springfield Hospital Forensic Department. 7. Experiences in France and England: A Patient's Perspective, Anonymous. Part II: Seeking a Better Balance 8. Developing a Mental Health Service for Ethnic Minorities, Albert Persaud, Wiltshire Health Authority. 9. Supporting Black Patients in Secure Care, Chinyere Inyama, Law Society Mental Health Review Tribunal Panel. 10. Change and Progress: The Right Pace?, Georgina Linton, High Security Forensic Psychiatry Commissioning Board. Part III: Clinical Perspectives 11. Fair Treatment for Black Patients in Secure Care, Chandra Ghosh, Broadmoor Hospital. 12. Black Men in Broadmoor Hospital, Stan Grant, Independent Trainer and Counsellor. 13. Providing Clinical Care for Black Patients, Harvey Gordon, Broadmoor Hospital Authority. 14. Black Staff and their Experience at Work, Krishnan Gnanasekaran, Broadmoor Hospital Training and Education Centre. 15. Black Women Patients in the Forensic Service, Margaret Orr, Broadmoor Hospital Authority. 16. Asian Women and Community Care, Alia Khan, Katherine Knapp House. Part IV: Effecting Change 17. Making Policy Work, Jayne Hayes. 18. Measuring Progress and Improving Quality, Jane Mackenzie and Carol Morgan-Clark, Broadmoor Hospital Authority. 19. Translating a Vision into Reality: Broadmoor's Partnership with ACHMA, Elaine Elvey, ACMHA. 20. Meeting the Spiritual Needs of Muslim Patients, Nizar Boga. 21. The Experience of Being a Black Patient, Anonymous. 22. Progress in Broadmoor Hospital, Tony Lingiah, Broadmoor Hospital Authority. The Contributors. Bibliography. Index

Read more less

Book SynopsisWorking with Sex Offenders in Prisons and through Release to the Community is the first study of its kind to look at a wide range of issues and problems relating to the management of sexual offenders in prisons and their reintegration into the community. Spencer's analysis of the delivery of prison-based offence-specific programmes, both within the broader context of criminal justice systems and the community provides valuable insight into the relationship between prisons and other agencies dealing with sex offenders. Spencer makes a strong case for implementing treatment for sexual offenders within prisons, as well as the need for support and supervision in the community once released. His multi-agency approach is an innovative and cohesive strategy for effective interventions, and highlights major issues which need to be addressed so that programmes stand a chance of succeeding in a penal setting.The issues involved in the setting up of programmes, the creation of the right environment, and the support and training of staff, are universally applicable; as are discussions of risk assessment, the links between victims and offenders, sex offenders in special hospitals, women as sex abusers, the use of pornography and sexual offender notification. This book is essential reading, not only for specialists in the field, but also for students and professionals working in related areas.Trade ReviewThis is an important book…[it] correctly sticks to the actual structure of the sex offender programme in Edinburgh. It tackles some tricky issues, but, mercifully, in an indirect manner…I would commend it wholeheartedly as a serious work in an area that is poorly covered -- Therapeutic CommunitiesThis book is essential reading for those working in prisons where sexual offenders are being treated or where there are plans to implement treatment programmes. It is an invaluable source of information not only for a variety of staff ranging for senior prison staff to programme facilitators and on line officers, but also for students and professionals working in related areas. It aims to look at a wide range of of issues and problems relating to the management of sexual offenders in prisons and their reintegration into the community.A variety of important discussions are considered in this book, including definitions of sexual offending, motivations to offend sexually, women as sex abusers, mentally disordered offenders, the use of pornography,notification of information on sex offenders and the link between victims and offenders.It is refreshing to read a book that delivers more than it promises. It is also unusual to find a text that focuses on the necessary operational and human resource requirements and considerations for quality treatment delivery. The author is to be commended for addressing many of these difficult issues. Spencer has gathered rich observations, interesting experiences and makes recommendations that are a smooth blend of pragmatism and principle. The author is considerate toward the reader, summarising the key points throughout each chapter. Useful case studies from the intervention programme are included in an appendix and the author provides an original flavour by including a prisoner account of treatment. The text is well structured and easily readable. The author has succeeded in presenting a careful, forthright analysis, couched in facts rather that verbal flatulence that represents a welcome shift away from criminological sex offender myopia. This is not just a useful supplement to existing texts but also an invaluable addition to the ongoing debate surrounding the treatment of sexual offenders. -- The British Journal of Forensic PracticeSpencer's analysis of the delivery of prison-based offence-specific programmes, both within the broader context of criminal justice systems and the community provides insight into the relationship between prisons and other agencies dealing with sex offenders. -- New LifeTable of ContentsForeword. Dedication. Preface. 1. Introduction. 2. Sexual Offenders and Their Victims. 3. Creating an Integrated Approach within a Prison Service. 4. Other Issues for Prisons. 5. The Programme. 6. Complementary and Supporting Programmes. 7. Monitoring and Evaluation. 8. Staff Training and Support. 9. Information about Offending Behaviour. 10. Bridging the Gap - I. Throughcare, the Multi-agency Approach. 11. Bridging the Gap - II. From Prison to Home and the Community. 12. Other Mult-agency Issues. 13. The Prisoner's Tale. 14. Postscript 15. A Model for Multi-agency Case Work. Annexe One: Case Studies from the STOP Programme. References. Index.

Read more less

Book SynopsisWritten by experts in the growing field of forensic mental health care, this book explores current and emerging interventions in forensic nursing and the care of the mentally disordered offender, with an emphasis on clinical practice and clinical competence. It explores the practical issues facing forensic nurses, such as environment and safety issues, as well as the possible emotional trauma of such a role. It examines a range of intervention strategies, such as exercise, which has often been used as an occupational time-filler, but also offers real therapeutic benefits. The contributors cover a range of diverse perspectives from the care of women in secure services, severely assaultive patients and sex offenders, the role of inpatient therapy and nurse therapists and the importance of spiritual nursing and educational interventions. The book also examines the client group itself and considers new roles for nurses in the light of recent research.The contributors to this volume take a wide-ranging approach, providing a comprehensive overview of current and future therapeutic interventions for forensic mental health care. Therapeutic Interventions for Forensic Mental Health Nurses is essential reading for all practitioners, nurses and educators in the forensic nursing field.Trade ReviewThis book is yet another from the excellent Forensic Focus series available from Kingsley. It brings together authors who are recognised nationally and internationally for their contemporary contributions in forensic mental health nursing ... Nurses who want to provide some future direction and alternative therapeutic options for their service, would do well to start with this text. -- ProquestFew books are more desperately needed than this, as forensic mental health nursing struggles to develop its credibility amid public and professional criticism. ... The editors have amassed a wide array of contributors, both from within and outside the field of forensic practice and theory. The chapters are generally well written and offer a lively debate from diverse perspectives. -- Mental Health TodayTable of ContentsForeword, Malcolm Rae. 1. Introduction, Alyson M. Kettles, Royal Cornhill Hospital, Phil Woods, University of Manchester and Mick Collins, Rampton Hospital Authority. 2. The implications of clinical governance for forensic nursing, John Gibbon, Rampton Hospital Authority and Alyson M. Kettles, Royal Cornhill Hospital. 3. Exploring the interface of competence and clinical effectiveness, Carol Watson, The State Hospital Carstairs. 4. Nursing interventions and future directions with patients who constantly break rules and test boundaries, Penny E. Schafer, University of Saskatchewan. 5. Using psychoeducational interventions within an integrated psychological approach to forensic mental health and social care, Stephan D. Kirby, St Lukes Hospital and Dennis Cross, School of Health, University of Teesside. 6. Nursing interventions and future directions with the severely mentally ill, Paula Ewers, Scott Clinic and Paul Ikin, Scott Clinic. 7. Nursing interventions and future directions with severely assaultive patients, Mark Chandley, Ashworth Hospital Authority. 8. Nursing interventions and future directions with exercise therapy, Lesley Adams, Royal Cornhill Hospital. 9. Nursing interventions and future directions with women in secure services, Anne Aiyegbusi, Ashworth Hospital Authority. 10. Nurse therapy in forensic mental health, Paul Rogers, Glanrhyd Hospital and Kevin Gournay, Institute of Psychiatry. 11. Nursing interventions and future directions with sex offenders, Mary Addo, Royal Cornhill Hospital. 12. Socially constructed narrative interventions: a foundation for therapeutic alliances Stephan D. Kirby, St Lukes Hospital and Dennis Cross, School of Health, University of Teesside. 13. Spiritual care in forensic nursing: spiritual interventions and future directions for care, John Swinton, King's College, University of Aberdeen. 14. Nursing interventions and future directions in community care for mentally disordered offenders, Helen Edment, Glasgow Forensic Outreach Team. 15. Forensic nursing interventions and future directions for forensic mental health practice, Phil Woods, University of Manchester, Mick Collins, Rampton Hospital Authority and Alyson M. Kettles, Royal Cornhill Hospital. References. Index.

Read more less

Book SynopsisDesigned to bridge the gap between normal histology and pathological alterations, Mills’s Histology for Pathologists, 6th Edition, offers a unique pathologic perspective on normal histology, highlighted by almost 2,000 high-quality illustrations. Written by anatomic pathologists for anatomic pathologists, and newly edited by Dr. Rhonda K. Yantiss, this award-winning, comprehensive classic has been updated with new information on surgical principles and techniques. Ideal for all anatomic pathologists as well as those in training, this updated volume continues to adhere to Dr. Stephen S. Sternberg’s original purpose as articulated by Dr. Stacey E. Mills: “While normal does not change, our perception of normal continues to expand and improve. We also continue to recognize new variations of normal that cause diagnostic confusion and touch on the interface between normal and disease.” Focuses on variations of the norm related to such variables as age, sex, and race often not clarified in conventional textbooks Emphasizes normal histology and normal features that may be confused with pathologic conditions, and briefly discusses prepathologic conditions and pathologic processes confused with normal Features almost 2,000 new and updated gross and microscopic images, including immunohistochemical stains and special stains Reflects recent advances in immunohistochemical and molecular techniques that provide insights into pathologic processes, as well as increased awareness of the spectrum of normal findings Shares the knowledge and fresh perspectives from many new authors, as well as new editor Dr. Rhonda K. Yantiss, whom Dr. Stacey E. Mills chose to continue the tradition of excellence established in previous editions of this text

Read more less

Book SynopsisIn this updated edition, leading medical specialists critically review for the general practitioner the latest techniques for the clinical management of diabetic neuropathy. The contributors focus on the practical aspects of diabetic neuropathy and describe in detail the treatments that are currently available or expected to become available in the near future. They also include concise discussions of the pathogenesis of diabetic neuropathy.Table of ContentsPlease see attachment for detailed chapter author list and chapter outlines.

Read more less

Book SynopsisThis book is the 2nd improved and expanded edition of "Clinical Enzymology" (Lott/Wolf, 1987). It includes case studies and guidelines for specialists of laboratory medicine and clinicians, devotes each chapter to a specific enzyme or protein marker, contains case studies and guidelines, a section on marker biochemistry and physiology as well as a section on special pathology and analysis. The clear, didactic structure and the multiple choice questions also make the book valuable reading for graduate students in the fields of clinical pathology and laboratory medicine.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisCongenital glaucoma is a complex problem, which has been a frequent cause of blindness in the past. Over the past decades, the prognosis of congenital glaucoma has completely changed. Surgical results are very good and enable these children to integrate entirely as adults in society.Based on the authors’ accumulated experience of more than 50 years and 860 cases operated for congenital glaucoma, this well-structured and lavishly illustrated textbook-atlas covers all aspects of congenital and infantile glaucoma, such as the original method for examining new-borns under general anaesthesia in the slit-lamp, the signs and symptoms of the disease and the differential diagnosis, the role and importance of the echometry value for early diagnosis, the gonioscopy results and the three types of congenital glaucomas (pure, refractory and late) and the type of surgery to be performed in each case with the evaluation of follow-up long-term results. Written by renowned international experts of the field, this book will become the golden standard in the field of Pediatric and Congenital Glaucomas.Trade ReviewFrom the reviews:"It is a comprehensive presentation of the diagnosis, treatment, and pathology of the various causes of glaucoma in children. … This work is intended for ophthalmologists who care for children with glaucoma. Its detailed figures and descriptions of surgical techniques make it ideal for glaucoma surgeons in training as well as practicing glaucoma specialists. … This book provides a unique and authoritative discussion of the diagnosis and surgical treatment of pediatric glaucoma." (Monte Dean Mills, Doody’s Review Service, May, 2009)“This hard-cover book … is divided into 28 chapters on different aspects of congenital glaucoma for specialists and residents. … The book is full of images, which makes it user-friendly… . All in all I would recommend this book, which is certainly a good asset for every glaucoma specialist to have as a reference.” (Michele Iester, Graefe’s Archive for Clinical and Experimental Ophthalmology, Vol. 248, 2010)“Pediatric glaucomas is probably the most interesting and in-depth books on this topic I have ever read. … I highly recommend Pedriatic glaucoma. Besides being a valuable tool for ophthalmologists that deal with this fascinating and difficult topic, this book is surely beneficial for all doctors in search of greater knowledge beyond our modern technological world, which often causes us to forget about the ethical, humane, and non instrumental aspects of our day-to-day clinical work.”­­­ (Paolo Brusini, European Journal of Ophthalmology, 2011)Table of ContentsPrimary Congenital Glaucoma.- Pediatrics Glaucoma. Classification.- Clinical Features.- Examination of the Newborn Under General Anesthesia.- Normal Intraocular Pressure in Children from Birth to Five Years of Age.- Ocular Echometry in the Diagnosis of Congenital Glaucoma.- Genetics in Congenital Glaucoma.- Ocular Embryology with Special Reference to Chamber Angle Development.- The Anatomy of the Chamber Angle.- Examination of the Chamber Angle.- Normal Chamber Angle in the Adult: Gonioscopic Images.- Normal Chamber Angle in Newborns and Children.- Pathological Chamber Angle in Congenital Glaucoma and Its Implications in Indications for Surgery.- Clinical History for Congenital Glaucoma.- Surgery for Congenital Glaucoma.- Results of Surgery for Congenital Glaucoma.- Optic Nerve.- Visual Field in Congenital Glaucoma.- Differential Diagnosis of Primary Congenital Glaucoma.- Goniodysgenesis or Late Congenital Glaucoma. Pigmentary Glaucoma.- Congenital Glaucoma Associated with Ocular Malformations.- Congenital Glaucoma Associated with Ocular and Somatic Malformations.- Congenital Glaucoma Associated with Congenital Errors of the Metabolism.- Congenital Mesodermal Dystrophies.- Nonhereditary Congenital Glaucomas.- Anatomopathologic Evaluation in Pure Congenital Glaucoma.- False-Positive Diagnoses.- Epilog.

Read more less

Book SynopsisGOETHE bemerkt in seinen "Maximen und Reflexionen": "Zur Verewigung des Irrtums tragen die Werke besonders bei, die enzyklopädisch das Wahre und Falsche des Tages überliefern. Hier kann die Wissenschaft nicht bearbeitet werden, sondern was man weiß, glaubt, wähnt, wird aufgenommen; deswegen sehen solche Werke nach fünfzig Jahren gar wunderlich aus. " Diese kritische Einstellung zum "Handbuch" hatte ich vor Augen, als ich mit den Vorbereitun­ gen für den Band "Mikrozirkulation" begann. Den Mut, dennoch ein nicht abgeschlossenes Werk vorzulegen, begründe ich damit, daß die Sorge, zur Ver­ ewigung des Irrtums beizutragen, für das heutige Verständnis der Wissenschaft nicht mehr gilt. Zwar halten manche Forscher daran fest - und das ist auch ihr gutes Recht - zu versuchen, einmal Erarbeitetes mit neuen Methoden oder durch ergänzende Befunde zu bestätigen und zu erhärten, im Grunde geben sie aber durch ihre weiteren Arbeiten zu - und sie sind auch darauf gefaßt -, daß jeder einzelne Befund, jede Grundlage und jede entwickelte Hypothese sich als falsch erweisen kann. Diese skeptische Grundhaltung der Forscher gegen­ über den Ergebnissen der Wissenschaft rührt daher, daß sie einerseits nicht mehr glauben, sich mit Hilfe der Wissenschaft jemals der Wahrheit direkt versi­ chern zu können, andererseits können sie Glauben im Sinne des Fest-für-wahr­ Haltens in der Wissenschaft nicht gelten lassen. In dem Bestreben, die Dinge kritisch und realistisch zu sehen, bemühen sich die theoretischen, d. h.Table of Contents/ Contents.- Angioarchitektonik der terminalen Strombahn.- A. Angioarchitektonik, allgemein.- I. Definition und Einleitung.- II. Kapillaren, Bau und Funktion.- III. Präteminale Strombahn, Bau.- IV. Präkapilläre Sphinkteren, Bau und Vorkommen.- V. Postterminale Strombahn, Bau.- VI. Arteriovenöse Anastomosen.- 1. Echte arteriovenöse Anastomosen.- 2. Arteriovenöse Anastomosen ohne besonderen Wandbau.- a) Leitersprossen.- b) Direkte arteriovenöse Übergänge.- c) Zentralkanäle (a.-v.-bridges, thoroughfare channels in Mesenterien).- d) Arteriovenöse Kurzschlüsse an anderen Geweben.- B. Angioarchitektonik. spezielle.- I. Definition und Einleitung.- 1. Netzkapillargebiete. zu- und ableitende Blutgefäße.- 2. Schlingenförmige und aufgeknäuelte Kapillargebiete.- II. Netzkapillarsysteme.- 1. Flächenhaft entwickelte Kapillarnetze an planen Geweben.- a) Mesothelduplikaturen, Kapillarnetze.- b) Mesothelduplikaturen, Gefäßsonderfomen.- c) Flächenhaft entwickelte Kapillarnetze, Verschiebegewebe.- d) Faszien, Organkapseln, Periostabschnitte, Perichondrium, Periorbita, Dura mater und andere Kapillargebiete.- e) Subepitheliale Kapillarnetze, die vonviegend Schleimhäute unterfüttern, Übergang zum räumlichen Kapillarnetz.- f) Subepitheliale Kapillarnetze als Übergangsstadien.- g) Blutgefäße des Ureters.- h) Regio respiratoria.- III. Netzkapillaren an kompliziert gestalteten Oberflächen.- 1. Villi intestinales, Blutgefäßsystem.- 2. Netzkapillarsystem um zapfen- und schlauchförmige, gerade und aufgeknäuelte Einstülpungen des Epithels.- a) Kapillaren des Haarbalgs.- b) Schweißdrüsen, Versorgung.- c) Glandulae sudoriferae apocrinae.- d) Glandulae sebaceae.- 3. Blutgefäße der Mamma.- 4. Blutgefäße der Speicheldrüsen.- 5. Lungenalveolen.- 6. Darmkrypten.- 7. Glandula thyreoidea.- 8. Gallenblasenschleimhaut.- IV. Räumliche Netzkapillarsysteme und Organkreisläufe.- 1. Gehirn.- a) Durchblutung und arterielle Anastomosen.- b) Hirnarterien.- c) Gehirnkapillaren.- d) Hirnvenen.- e) Cerebrum, Angioarchitektonik.- f) Angioarchitektonik des Großhirnmarks.- g) Cerebellum, Angioarchitektonik.- h) Kapillardichte, allgemeine.- i) Kapillardichte, Entwicklung.- k) Kapillarweite und -länge und Volumenanteil.- V. Rückenmark, terminale Strombahn.- 1. Zustrombahnen.- 2. Rückenmarkkapillaren, Bau.- 3. Abstrombahnen.- 4. Ein- und Austrittspforten der Rückenmarkgefäße.- VI. Spinalganglien und Kopfganglien. Vaskularisation und Angioarchitektonik.- VII. Periphere Newen. Vaskularisation und Angioarchitektonik.- VIII. Skelettmuskel — dreidimensional, „rüumliche“ Kapillarnetze.- 1. Terminale Strombahn im Skelettmuskel, allgemein.- 2. Prüterminale Anastomosen.- 3. Skelettmuskel, Kapillaren-Bau.- 4. Skelettmuskel, Kapillarabstände.- 5. Kapillaren, Angioarchitektonik.- 6. Abstrombahn im Skelettmuskel.- IX. Herzmuskulatur, Angioarchitektonik.- 1. Versorgungstypen.- 2. Kapillarbett.- 3. Kapillardichte, Veränderung.- 4. Herzkapillaren, Entwicklung.- X. Angioarchitektonik der Leber.- XI. Magen-Angioarchitektonik.- XI1. Duodenum, terminale Strombahn.- XI11. Schlingen- und knäuelförmige Kapillaren der Haut.- 1. Haut — terminale Strombahn.- 2. Kapillaraneurysmen.- 3. Nagelfalzkapillaren, Form.- 4. Hautkapillaren, regionale Unterschiede ihrer Anzahl.- 5. Schlingenkapillaren der Haut — Entwicklung und Alterung.- 6. Hautgefäße. arterielle Zustrombahnen.- 7. Arteriennetze.- 8. Schlingenkapillaren in anderen Organgebieten.- XIV. Gefäßwand — terminale Strombahn.- 1. Arterienwand, Gefäßversorgung — Vasa vasorum.- 2. Venenwand — terminale Strombahn.- Literatur.- Bau und Funktion der Blutkapillaren.- A. Allgemeine Einleitung.- I. Historischer Überblick und Lichtmikroskopie der Blutkapillaren.- 1. Das Endothel.- 2. Die Basalmembran.- 3. Die Perizyten.- B. Die Ultrastruktur der Blutkapillaren.- I. Einleitung.- II. Definition und Klassifikation der Blutkapillaren.- III. Allgemeiner Feinbau der Blutkapillaren.- 1. Vorkommen und Funktion spezieller Zellstrukturen.- a) Mikrotubuli und Filamente.- b) Weibel-Palade-Körperchen (WPK).- c) Stabile Oberflächendifferenzierung des Endothels.- ?) Tentakeln.- ß) Randwülste.- ?) Mikrovilli.- ?) Basale Endothelfüßchen.- d) Mikropinozytotische Vesikel.- ?) Struktur, Verteilung und quantitative Angaben.- ß) Funktionelle Bedeutung im Rahmen normaler und gesteigerter Per-meabilität („large pore system“).- e) Fenestrationen.- ?) Vorkommen, Verteilung. Struktur und quantitative Angaben.- ß) Funktionelle Bedeutung im Rahmen der Permeabilität („large and small (?) pore system“).- 2. Die Interzellularfugen.- a) Gestalt, interzellulärer Zement und endokapillarer Eiweißfilm.- b) Interendotheliale Kontaktstrukturen und Passagewege („small pore system“).- 3. Histochemie des Endothels.- 4. Die Basalmembran.- a) Definition und Dimension sowie chemische und strukturelle Zusammensetzung.- b) Funktionelle Bedeutungen (Barriere für den Stoffaustausch, Antigenität und mechanische Aufgaben).- 5. Die Perizyten.- a) Verteilung, Gestalt und Struktur.- b) Funktionelle Bedeutung.- Literatur.- Hernodynamics of the Microcirculation. Physical Characteristics of Blood Flow in the Microvasculature.- 1. Introduction.- 2. Methodology: New Techniques for Quantitative Measurement of Hemodynamic Parameters in the Microcirculation.- a) Intraluminal Pressure.- b) Microvascular Diameter.- c) Flow Velocity and/or Volume Flow in Microvessels.- 3. Morphometric Considerations.- 4. Distribution of Intraluminal Pressures Within the Microcirculation.- a) Structural Factors in Pressure Dissipation.- b) Effect of Changes in Systemic Pressure.- c) Capillary Pressure.- d) Pulsatile Pressures in Microvessels.- 5. Distribution of Flow Velocity and/or Volume Flow Within the Microcirculation.- a) Pulsatility of Microvascular Blood Flow.- b) Intermittency of Blood Flow in Capillaries.- c) Velocity Profiles in Microvessels.- 6. Bolus Flow in Capillaries.- 7. Transit Times of Cells and Plasma Through the Microcirculation.- 8. Distribution of Hematocrit Within the Microcirculation.- References.- Microrheology of Erythrocytes and Thrombocytes Blood Viscosity and the Distribution of Blood Flow in the Microcirculation.- The Present State of Blood Rheology.- Rheological Problems in the Microvasculature.- Description of the Flow Conditions in vivo: Hydrodynamic Analysis of the Vascular Bed.- Meaning and Measurement of the “Viscosity of Blood”.- Blood Viscosity in vitro.- Small Bore Tubes—The Fahraeus Effect.- Analysis of Blood Microrheology : Observation, Photometry and Viscometry.- Photometric Aggregometry.- Factors Operational in Red Cell Aggregation.- Shape and Deformation of Red Cells: The Concept of Conformational Instability.- Disturbed Red Cell Deformability: Conformational Stability.- “Blood Viscosity” in vivo.- Blood Viscosity and Hemodynamics.- Relative Rôle of Vasomotor and Viscosity Factors.- Rheology of Intravascular Red Cell Aggregation and Dissociated Microvascular Perfusion: Stasis and Shunting.- Rheology of Thrombocytes.- Rheological Factors in Platelet Aggregation and Fibrin Formation — Methodological Aspects.- Interaction of Flow Forces with Platelet Convection, Collision, Interaction, Disruption.- Rheological Aspects of Hemostasis and Thrombosis.- Effects of Platelets on Fibrin Polymerization.- Summary :Mixed Thrombotic Processes: Interaction of Red Cell and Platelet Aggregation with Fibrin Formation.- References.- The Interstitial Tissue Pressure and Microcirculation.- A. Introduction.- B. Structural Aspects of the Interstitial Space.- I. Biochemical Components of the Interstitial Space.- II. Physical Characteristics of the Interstitial Tissue Structures.- III. The Heterogeneous Structure of the Interstitial Space.- C. Methods of Measuring the Interstitial Tissue Pressure.- I. Needle Technique.- II. Capsule Technique.- III. Wick Technique.- IV. Balloon Technique.- V. Critique of the Methods.- D. The Physiological Significance of Measuring the Interstitial Fluid Pressure.- I. Results of Earlier and Recent Measurements.- II. The Compliance of the Interstitial Space.- III. The Interrelationship of Tissue Compliance and Body Fluid Control.- E. Summary and Conclusions.- References.- Exchange Processes in the Microcirculatory Bed.- A. Fluid Movement through Membranes by Hydrostatic Forces.- B. Movement of Substances through Membranes by Diffusion.- I. Free Diffusion.- II. The Diffusion Coefficient.- III. Restricted Diffusion through Membranes.- IV. Molecular Sieving by Restricted Diffusion and Filtration through Membranes.- C. The Movement of Fluids through Membranes by Osmotic Forces.- I. Ideal Semipermeable Membranes.- II. Nonideal Semipermeable Membranes.- D. The Movement of Fluids and Solutes through Membranes by Combined Hydrostatic and Osmotic Forces.- E. Movement of Fluid through the Capillary Wall.- I. Intraluminal Factors.- II. Extraluminal Factors.- III. Drainage by Lymphatic Vessels.- IV. Filtration Coefficient of Water.- F. The Movement of Solutes through the Capillary Wall.- I. Measurements of Permeability of the Capillary Wall from Lymph-Plasma Concentration Ratio.- II. Measurements of Permeability of the Capillary Wall by Osmotic Transients.- III. Measurements of Capillary Permeability by Indicator Dilution Methods.- IV. Measurement of Capillary Permeability by Measuring Tissue Clearance after Direct Application of Indicator to the Tissue.- V. Regulation of Permeability and Discussion of the Results.- G. Exchange of Gases.- I. Inert Gases (Arterial Administration).- II. Inert Gases (Direct Application to the Tissue).- III. Oxygen and Carbon Dioxide Exchange with the Tissue.- Summary.- References.- Morphologische Reaktionsmuster der terminalen Strombahn.- 1. Einleitung.- 2. Die gestörte Barrierewirkung der terminalen Strombahn.- 2.1. Die veränderte Gefäßwand.- 2.1.1. Lecks im Endothelverband.- 2.1.2. Transzelluläre Gefäßpermeabilität.- 2.1.3. Das subendotheliale Grundhäutchen (Basalmembran).- 2.1.4. Perivaskuläre Barrieren.- 2.1.5. Die Bilanz der gestörten Permeabilität.- 2.2. Ablagerung von Bestandteilen des Blutplasmas.- 2.2.1. Arteriolosklerose.- 2.2.2. Ablagerungen (Deposits).- 2.2.3. Ödeme.- 2.2.4. Lipide, Gallenfarbstoffe, Silber, Kalk.- 2.2.5. Amyloid.- 2.3. Passage von Blutzellen.- 2.3.1. Erythrozyten.- 2.3.2. Leukozyten, Monozyten, Lymphozyten.- 2.3.3. Thrombozyten.- 2.3.4. Bakterien, Pilze, Tumorzellen.- 3. Veränderter Stoffwechsel der Gefäßwand.- 3.1. Veränderte Zellen.- 3.1.1. Hyperplasie, Hypertrophie, Zellschwellung.- 3.1.2. „Virusartige“ Zelleinschlüsse und Kernkörper.- 3.1.3. Abgelagerte Stoffwechselprodukte.- 3.1.4. „Metaplasie“ der Zellen.- 3.1.5. Zellverlust und -schädigung.- 3.2. Entstehung, Verlängerung und Rückbildung von Kapillaren.- 3.3. Die Pathologie der Basalmembran und der Mesangiumsubstanz.- 3.3.1. Die Basalmembran.- 3.3.1.1. Verdickung der Basalmembran.- 3.3.1.2. Strukturveränderung.- 3.3.1.3. Mangelhaft ausgebildete oder defekte Basalmembran.- 3.3.2. Die Mesangiumsubstanz.- 3.3.2.1. Vermehrung der Mesangiumsubstanz.- 3.3.2.2. Strukturänderung der Matrix.- 3.3.3. Kollagen.- 4. Veränderter Gefäßinhalt.- 4.1. Fettembolie.- 4.2. Eiweißpräzipitate.- 4.3. Zellaggregate.- 4.4. Intravasale Koagulation.- 4.5. Intravasale Zelltrümmer, Lumeneinengung.- 5. Schlußbetrachtungen.- Literatur.- Die allgemeine submikroskopische Pathologie der Endothelzellen und ihre Bedeutung für die Mikrozirkulation.- A. Einleitung.- B. Bemerkungen zur Ultrastruktur der Blutkapillaren.- C. Allgemeine submikroskopische Pathologie des Kapillarendothels.- I. Vorbemerkung.- II. Der Zellkern.- III. Die Zellmembran.- IV. Das Zytoplasma.- V. Die Zellgrenzen.- VI. Die Basalmembran.- VII. Veränderungen der Endothelzellen als Ganzes.- 1. Die osmiophile Verdichtung.- 2. Die Hypertrophie.- 3. Das Zellödem und die Schwellung.- 4. Die Nekrose.- D. Die Bedeutung der submikroskopischen Pathologie der Kapillarendothelien für die Mikrozirkulation der Organe.- I. Herzmuskel.- 1. Ischämie und Herzinfarkt.- 2. Hypoxidosen.- a) Vorbemerkung.- b) Atmosphärischer Unterdruck.- c) Hypoxie.- d) Anoxie.- e) Aderlaß-Oligämie.- f) Abfall des koronaren Perfusionsdruckes.- g) Druck- und Volumenüberlastung des Herzens.- h) Emotionaler Streß.- i) Kortikosteroide.- k) Katecholamine.- 1) Medikamentöse Einflüsse.- m) Stoffwechseleinflüsse.- 3. Vergiftungen.- a) Vorbemerkung.- b) Kohlenmonoxyd.- c) Kohlendioxyd.- d) Oxydationshemmende Gifte.- e) Kontraktionshemmende Substanzen.- f) Antifibrillatorische Substanzen.- g) Sonstige Gifte.- 4. Bestrahlungsfolgen.- 5. Infektiöse Einflüsse und Entzündungen.- II. Skelettmuskel.- 1. Ischämie.- 2. Blutstauung, Stauungsödem.- 3. Toxisches Ödem.- 4. Anaphylaktoides Ödem.- 5. Bestrahlungsfolgen.- 6. Kälteeinwirkung.- III. Nervensystem.- 1. Vorbemerkung.- 2. Hirnödem.- 3. Hypoxie und Anoxie.- 4. Ischämie.- 5. Bluthochdruck.- 6. Bestrahlungsfolgen.- a) Direkte Strahlenschäden.- b) Akzessorische Schäden durch Kontrastmittel.- 7. Traumatische Veranderungen.- IV. Lungen.- 1. Vorbemerkung.- 2. Hyperventilation, Emphysem, Lungenkollaps.- 3. Hyperoxie.- a) Normobare Hyperoxie.- b) Hyperbare Hyperoxie.- c) Ozon.- 4. Atemnotsyndrom.- 5. Atmosphärischer Unterdruck.- 6. Hypoxie.- 7. Hämorrhagischer Schock, Histaminschock.- 8. Blutstauung.- 9. Ödem.- 10. Stoffwechseleinflüsse.- 11. Vergiftungen.- a) Paraquat.- b) Kohlenmonoxyd.- c) Kohlendioxyd.- d) Monocrotalin.- e) Bleomyzin.- 12. Fettembolie.- 13. Immunologische Reaktionen.- 14. Idiopathische Lungenhämosiderose.- 15. Direkte Wassereinwirkung auf die Lungen.- 16. Bestrahlungsfolgen.- 17. Infektiöse Einflüsse.- V. Nieren.- 1. Vorbemerkung.- 2. Ischämie.- 3. Venöse Blutstauung.- 4. Schock.- 5. Kortikosteroide.- 6. Vergiftungen.- a) Sublimat.- b) Schlangengift.- c) Bromäthylaminhydrobromid.- 7. Bestrahlungsfolgen.- 8. Glomeruläre Nephropathien.- E. Mikrozirkulation und Organpathologie.- F. Summary and Conclusions.- Literatur.- Capillary Platelet and Fibrin Thrombosis.- A. Introduction.- I. Pathophysiologic Responses of the Microcirculation.- 1. Response to Injury.- 2. Microcirculation versus Macrocirculation.- 3. Response and the Strength of Injurious Stimuli.- II. Response to Degenerative Diseases.- III. Species Differences in Responses.- B. Methods of Studying Thrombosis in Vivo.- I. Methods for Experimental Observation in Animals.- 1. Quartz Rod Methods.- 2. Exteriorization of Viscera.- 3. Transparent Chambers.- 4. Superficial Tissues.- II. Methods for Clinical Investigation in Humans.- C. Experimental Microcirculatory Thrombogenesis in Animals.- I. Systemic Processes.- 1. Infusion of Thrombin and Tissue Extracts.- 2. Infusion of Other Enzymes.- 3. Infusion of Adenosine Diphosphate.- 4. Infusion by Collagen.- 5. Infusion of Fatty Acids and Other Acids.- 6. Infusion of Incompatible Blood.- 7. Infusion of Antigen-Antibody Complexes.- 8. Infusion of Bacteria and Toxins.- 9. Infusion of Viruses.- 10. Infusion of Rickettsia.- 11. Anaphylaxis.- 12.Shock.- 13. Decompression Sickness and Air Infusion.- II. Local Alterations.- 1. Local Application of Injurious Agents.- a) Trauma.- b) Thrombin and Adenosine Diphosphate.- 2. Other Means of Inducing Thrombi.- 3. Arthus Reaction.- 4. Local Shwartzman Reaction.- 5. Tissue Transplant Rejection.- D. Microcirculatory Thrombosis in Human Disease.- I. Endothelial Cell Alterations.- 1. Effects of Bacteria, Rickettsia, and Viruses.- 2. Effect of Hyperthermia.- II. Blood Cell Alterations.- 1. Platelet Alteration.- 2. Leukocyte Alteration.- 3. Erythrocyte Alteration.- III. Abnormal and Altered Plasma Factors.- IV. Disordered Blood Flow.- V. Iatrogenic and Unknown Factors.- VI. Transplant Rejection.- E. Comment.- Addendum.- References.- Microcirculatory Changes in Myocardium with Particular Reference to Catecholamine-induced Cardiac Muscle Cell Injury.- Objectives.- A. General Review.- I. Functional Anatomy of Coronary Microcirculation and Myocardium.- 1. Myocardial Blood Supply.- 2. Structural Aspects of Coronary Microcirculation.- 3. Exchange of Substances across Coronary Capillaries.- a) Fine Structural Correlates of Endothelial Permeability.- b) Studies with Fine Structural Protein Tracers.- ?) Junctional Passage.- ß) Vesicular Transport.- c) Regional Differences in Endothelial Permeability.- 4. The Regulation of Coronary Microcirculation.- a) Systemic Regulation.- b) Local Factors Regulating Coronary Microcirculation.- ?) Regional Differences in Coronary Microcirculation and Myocardial Perfusion.- ß) Increased Vulnerability of the Subendocardial Layer.- ?) Autoregulation.- 5. Methods for Measuring Coronary Blood Flow.- 6. The Functional Anatomy of Cardiac Muscle Cell.- 7. Myocardial Interstitium.- II. The Cardiovascular Effect of Catecholamines.- 1. The Role of Catecholamines in Cardiac Physiology.- 2. Human Cardiac Pathophysiology with Altered Catecholamine Homeostasis.- 3. Catecholamine-induced Myocardial Alterations.- 4. Forms of Ischemic (Hypoxic) Myocardial Lesions.- B. Experimental Studies on Catecholamine-induced Cardiac Muscle Cell Injury.- Fine Structural Morphology of the Catecholamine-induced Cardiac Muscle Cell Injury.- Materials and Methods.- Results.- 1. Morphologic Functional Correlative Studies on the Coronary Microcirculation.- a) Systemic Arterial Blood Pressure.- b) Passage of Fine Structural Protein Tracers Through Coronary Microvasculature.- 2. Permeability Alteration of Cardiac Muscle Cell Membranes.- Discussion.- General Summary.- Acknowledgement.- References.- Klinische Aspekte der Mikrozirkulationsstörungen unter besonderer Berücksichtigung des Schocks.- A. Einleitung.- B. Allgemeine Pathologie der Mikrozirkulationsstörung.- C. Pathophysiologie der Mikrozirkulationsstörung.- I. Das Syndrom der akuten Mikrozirkulationsstörung: Pathophysiologie und Klinik des Schocks.- 1. Definition und Einteilung.- 2. Die Störungen der Hämodynamik und ihrer Folgen.- 3. Die gestörte Mikrozirkulation im Schock.- a) Die schockspezifische Vasomotion.- b) Metabolische Folgen der verminderten O2-Zufuhr.- c) Die Änderung des Fließverhaltens des Blutes.- d) Diffuse intravaskuläre Gerinnung, Verbrauchskoagulopathie und sekundäre Fibrinolysesteigerung.- II. Schockspezifische Organveränderungen.- 1. Myocardiale Leistung und Coronarzirkulation.- 2. Lungenveränderung als Schockfolge.- 3. Änderung der Nierenfunktion im Schock und Schockniere.- 4. Die splanchnische Zirkulation und Perfusionsstörung der Leber (Schockleber).- 5. Das reticulo-endotheliale System.- D. Schlußbetrachtung.- Literatur.- Namenverzeichnis / Author Index.- Sachverzeichnis / Subject Index.

Read more less

Book SynopsisDieser Buchtitel ist Teil des Digitalisierungsprojekts Springer Book Archives mit Publikationen, die seit den Anfängen des Verlags von 1842 erschienen sind. Der Verlag stellt mit diesem Archiv Quellen für die historische wie auch die disziplingeschichtliche Forschung zur Verfügung, die jeweils im historischen Kontext betrachtet werden müssen. Dieser Titel erschien in der Zeit vor 1945 und wird daher in seiner zeittypischen politisch-ideologischen Ausrichtung vom Verlag nicht beworben.Table of ContentsVergleichende Physiologie des Verdauungsapparates.- Die Nahrungsaufnahme bei Protozoen.- Die Verdauungsvorgänge bei Protozoen.- Einige vergleichend — physiologische Probleme der Verdauung bei Metazoen.- Über tierverdauende Pflanzen.- Normale und pathologische Physiologie des Verdauungsapparates der höheren Tiere, insbesondere des Menschen.- Chemie der Kohlehydrate.- Chemie der Fette.- Chemie der Eiweißkörper.- Mechanik der Nahrungsaufnahme und Nahrungsbeförderung.- Kaubewegungen und Bissenbildung.- Schlucken.- Pathologie des Schluckaktes.- Das Wiederkauen.- Die Magenbewegungen.- Der Brechakt.- Bewegungen des Darmes.- Die Defäkation.- Die Pathologie der Bewegungsvorgänge des Darmes (einschließlich der Obstipation und der Defäkationsstörungen) und der extrahepatischen Gallenwege.- Pharmakologie der Magen- und Darmbewegung (einschließlich Wirkungen der Hormone).- Die sekretorische Tätigkeit des Verdauungsapparates und die Funktion der Sekrete.- Funktionelle Anatomie und Histophysiologie der Verdauungsdrüsen.- Gewinnung reiner Sekrete der Verdauungsdrüsen.- Die sekretorische Tätigkeit der Verdauungsdrüsen.- Physikalische Eigenschaften und chemische Zusammensetzung der Verdauungssäfte unter normalen und abnormen Bedingungen.- Die Galle.- Fermente der Verdauung.- Die Wirkungen der Mikroorganismen im Verdauungstraktus.- Einfluß der Mikroorganismen auf die Vorgänge im Verdauungstraktus bei Herbivoren.- Über die Wechselbeziehungen zwischen Bakterienflora und den Verdauungsvorgängen beim Säugling.- Der Einfluß der Mikroorganismen auf die Vorgänge im Verdauungstraktus beim erwachsenen Menschen.- Pathologie der Verdauungsvorgänge.- Vergleichende pathologische Physiologie der Verdauung.- Pathologische Physiologie der Speicheldrüsen.- Pathologische Physiologie des Magensaftes und des Magenchemismus.- Pathologische Physiologie spezieller Krankheitsbilder.- Die Motilität und Sekretion des operierten Magens.- Pathologische Physiologie der Darmdrüsen.- Die äußere Sekretion des Pankreas unter pathologischen Bedingungen.- Gallenabsonderung und Gallenableitung.- Physiologie und Pathologie der Ernährungs- und Verdauungsvorgänge im frühen Kindesalter.- Physiologie und Pathologie der Ernährungs- und Verdauungsvorgänge im frühen Kindesalter.- Pharmakologie der Verdauungsdrüsen.- Pharmakologie der Verdauungsdrüsen.

Read more less

Book SynopsisDieser Buchtitel ist Teil des Digitalisierungsprojekts Springer Book Archives mit Publikationen, die seit den Anfängen des Verlags von 1842 erschienen sind. Der Verlag stellt mit diesem Archiv Quellen für die historische wie auch die disziplingeschichtliche Forschung zur Verfügung, die jeweils im historischen Kontext betrachtet werden müssen. Dieser Titel erschien in der Zeit vor 1945 und wird daher in seiner zeittypischen politisch-ideologischen Ausrichtung vom Verlag nicht beworben.Table of ContentsAllgemeines über biogene Amine.- I. Die Alkylamine.- II. Die Alkanolamine (Alkamine).- III. Die Neuringruppe.- IV. Die Diamine.- V. Die Guanidinoverbindungen.- VI. Die Imidazolverbindungen.- VII. Die Betaine und ?-Aminosäuren.- VIII. Phenylalkyl- und Phenylalkanolamine.- IX. Das Indoläthylamin.- Schlußbetrachtungen.

Read more less

Book Synopsis

Read more less

Book SynopsisThe Italian Study Group on Cardiomyopathies organized in Florence in April 1997, eight years after the first successful meeting, the second international symposium devoted to "Advances in Cardiomyopathies". In these years exceptional progress has been made in the field of heart muscle diseases, in clinical research as well as in molecular biology, molec- ular genetics., pathophysiology and treatment. Many of these advances were presented and discussed in Florence by a distinguished team of international experts. Hypertrophic cardiomyopathy was addressed in ten papers; in the first one Seidman reported the results obtained by the use of molecular genetic tech- niques which showed that hypertrophic cardiomyopathy is a heterogeneous disorder caused by different mutations of different genes and discussed the clinical role and significance of genetic testing. Original data regarding the natural history and prognosis of symptomatic patients were obtained in the Italian multicentric study (Cecchi, Lazzeroni), while Baroldi discussed the clinico-pathologic spectrum of the disease in severely symptomatic patients treated with heart transplantation. Sudden death in the young (Basso), the identification and management of high risk patients (Elliott), the clinical importance and the problems of detec- tion of ischemia (Camici) were deeply discussed as well as the indications and results of different types of treatment: medical, surgical, DDD pacing (Spirito, Betocchi, Schoendube).Table of ContentsIntroduction: II Florence Meeting on Advances in Cardiomyopathies The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I.Natural History and Clinical Course of Unselected Patients Detection and Clinical Consequences of Myocardial Ischemia and, Reduced Coronary Reserve The Coronary Circulation is Dysfunctional in both Hypertrophied and Non-Hypertrophied Myocardium Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist's View Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients Medical Treatment of Heart Failure in Hypertrophic Cardiomyopathy DDD Pacing in HCM: State of the Art Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy Genetic Basis of Dilated Cardiomyopathy Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances Organ-specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications Inflammatory Cardiomyopathy: Diagnosis and Therapeutical Options Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy Molecular Biology of Cardiac Failure Dilated Cardiomyopathy: does Etiological Heterogeneity Portend Clinical Heterogeneity? The Natural History of Dilated Cardiomyopathy. The SPIC Registry 1986-1995. Therapeutic Strategies in Dilated Cardiomyopathy: Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis) Prevention of Sudden Death in Patients with Dilated Cardiomyopathy End-Stage Heart Failure and Timing of Heart Transplantation Beta-Blockers for Heart Failure: Practical Issues DDD Pacing in Dilated Cardiomyopathy Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies .

Read more less